Miruvor
Sign up
The short answer

What studies of Graded exercise therapy (GET) found

115papers on Graded exercise therapy (GET)
1,263people in 11 studies testing Graded exercise therapy (GET) alone
6randomised trials, the strongest kind of study

At a glance, by condition

ME/CFS: C Mixed results

Based on the strongest evidence, randomised trials and compared with another group, not randomised and studies with no comparison group and the randomised trial (very low certainty): 14 of 18 findings are C.

10 outcomes rated · see each below

How we got this

Each condition’s headline comes from its graded findings (one for each outcome and kind of study) rated with the highest certainty: the grade most of them share; a tie goes to the finding with the most people, then the most studies, then the outcome’s name. It sums up the grades below, and conditions are never combined.

What this means: Studies of Graded exercise therapy (GET) for ME/CFS disagree, so it’s not clear whether it helps. If you’re thinking about it, talk it through with a doctor who knows ME/CFS or long COVID.

Ask about this treatment

Sign up free to read the rest of what studies found.

You’ll see the full picture: how each symptom fared, every grade with its reasons, side effects and all 115 papers.

The grades, in plain words

Each outcome gets a direction, a certainty and a letter read from the two. Certainty is judged with GRADE, the method Cochrane and WHO use.

  1. A
    HelpsImprovement, high certainty
    Probably helpsImprovement, moderate certainty
  2. B
    May helpImprovement, low certainty
  3. Graded exercise therapy (GET) · ME/CFS is hereC
    Might help, very uncertainImprovement, very low certainty
    Mixed resultsStudies disagree
  4. D
    Little or no differenceStudies found little or no difference
  5. F
    HarmsIt made things worse

By symptom and daily life

ME/CFS

Symptoms

Fatigue8 studies · 541 people took part in Graded exercise therapy (GET) Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from controlled studies: risk of bias couldn't be judged for most results (ROBINS-I: no information); not all results were tested against chance; randomised trials found little or no difference.

Randomised trials5 studies · 1,029 people with results

No clear difference in fatigue.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on fatigue in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • No confidence interval shows an important benefit is ruled out
  • The studies disagree

Compared with another group, not randomised171 in the study · 148 with outcome data · Fourteen sessions; first 12 typically weekly or fortnightly; sessions 13 or 14 follow-up or booster · Fourteen sessions, the first 12 of these being typically weekly or fortnightly

Fatigue improved more than in the comparison group.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on fatigue in ME/CFS. Improvement · very low certainty C

  • Risk of bias couldn't be judged for most results (ROBINS-I: no information)
  • Not all results were tested against chance

Studies with no comparison group2 studies · 93 people with results

Fatigue improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on fatigue in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance

Combination: evidence based explanations of symptoms + Graded exercise therapy (GET) + educational information pack + seven planned telephone contacts + seven one hour face to face treatment se148 randomised

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. (2001): fatigue scale, better.

Shown, not counted: Graded exercise therapy (GET) was given together with other treatments.

See the 8 studies
  1. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. (2017)

    People in the study
    211 randomised · 102 analysed
    Dose
    six-step graded exercise programme, up to four guidance sessions with a physiotherapist over 8 weeks (maximum 90 min in total)
    Outcome
    Fatigue (CFQ) at 12 weeks Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012) (clinically significant reduction in fatigue)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (fatigue (CFQ))

    People in the study
    641 randomised
    Dose
    —
    Outcome
    fatigue (Chalder fatigue questionnaire score) Chalder fatigue questionnaire
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  3. Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: An exploratory pilot study. (2017)

    People in the study
    28 randomised · 24 analysed
    Dose
    eight individual training sessions of 50 minutes each at weekly intervals
    Outcome
    general fatigue Multidimensional Fatigue Inventory (MFI)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. (2024)

    People in the study
    241 randomised · 201 analysed
    Dose
    slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call
    Outcome
    Chalder Fatigue Chalder Fatigue scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  5. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    Physical fatigue
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  6. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome. (2016)

    People in the study
    171 in the study · 148 with outcome data
    Dose
    Fourteen sessions, the first 12 of these being typically weekly or fortnightly
    Outcome
    CGI positive change at posttreatment Clinical Global Impression (CGI)
    Effect
    better (not tested)
    Risk of bias
    ROBINS-I: No information
    Confounding
    Moderate. adjusted for: anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence change in anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence covariates entered as fixed effects
    Selection of participants
    Moderate. comparison group: patient preference Patient preference drove choice of therapy
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Ten CBT patients and seven GET patients dropped out without agreement; three patients each from CBT and GET ended therapy with therapist consent; prorated by adding a mean score value for missing items if a maximum of two scores were missing; data withdrawn if no consent at all three data points Ten CBT patients and seven GET patients dropped out of therapy without first agreeing to do so with their therapist. Three patients each from CBT and GET ended therapy with the consent of their therapist.
    Measurement of outcomes
    Moderate. administered or clinician-rated; assessors blinded: NI
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  7. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care - a benchmarking study. (2022)

    People in the study
    92 with outcome data
    Dose
    between 12 and 16, individual, one-hour sessions, generally once every two weeks
    Outcome
    Fatigue Chalder Fatigue Questionnaire
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  8. Does graded activity increase activity? A case study of chronic fatigue syndrome. (2002)

    People in the study
    1 in the study
    Dose
    daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions
    Outcome
    Fatiguea
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Low mood or anxiety5 studies · 325 people took part in Graded exercise therapy (GET) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (364 in all); the studies disagree; effect size 1.02 (large).

Randomised trials3 studies · 364 people with results

Low mood or anxiety improved more than in the comparison group.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on low mood or anxiety in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (364 in all)
  • The studies disagree
  • Effect size 1.02 (large)

How big was the difference?

1.02, large. The effect size compares Graded exercise therapy (GET) with control group (smc alone).

Studies with no comparison group2 studies · 93 people with results

Low mood or anxiety improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on low mood or anxiety in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance

Combination: evidence based explanations of symptoms + Graded exercise therapy (GET) + educational information pack + seven planned telephone contacts + seven one hour face to face treatment se148 randomised

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. (2001): depression (hospital anxiety and depression scale), better.

Shown, not counted: Graded exercise therapy (GET) was given together with other treatments.

See the 5 studies
  1. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. (2017)

    People in the study
    211 randomised · 102 analysed
    Dose
    six-step graded exercise programme, up to four guidance sessions with a physiotherapist over 8 weeks (maximum 90 min in total)
    Outcome
    HADS depression scale at 12 weeks Hospital Anxiety and Depression Scale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. (2024)

    People in the study
    241 randomised · 201 analysed
    Dose
    slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call
    Outcome
    Hospital Anxiety and Depression Scale: Depression Hospital Anxiety and Depression Scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    depression Hospital Anxiety and Depression Scale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care - a benchmarking study. (2022)

    People in the study
    92 with outcome data
    Dose
    between 12 and 16, individual, one-hour sessions, generally once every two weeks
    Outcome
    Depression Hospital Anxiety and Depression Scale
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  5. Does graded activity increase activity? A case study of chronic fatigue syndrome. (2002)

    People in the study
    1 in the study
    Dose
    daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions
    Outcome
    BAI and BDI scores Beck anxiety inventory
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Anxiety2 studies · 129 people took part in Graded exercise therapy (GET) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (201 in all).

The randomised trial241 randomised · 201 analysed · baseline, 6 and 12 months · slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call

Anxiety improved more than in the comparison group.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on anxiety in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (201 in all)

Studies with no comparison group26 with outcome data · before and after 12 weeks of GET

Anxiety improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on anxiety in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (26 in all)
See the 2 studies
  1. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. (2024)

    People in the study
    241 randomised · 201 analysed
    Dose
    slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call
    Outcome
    Spence Children’s Anxiety scale
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Influence of graded exercise therapy on anxiety levels and health-related quality of life in chronic fatigue syndrome. (2014)

    People in the study
    26 with outcome data
    Dose
    —
    Outcome
    trait anxiety (STAI-T) levels State-Trait Anxiety Inventory questionnaire (STAI)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Autonomic symptoms1 study · 32 people took part in Graded exercise therapy (GET) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (61 in all); effect size 1.17 (large).

The randomised trial68 randomised · 61 started · 61 analysed · 4 weeks' post-intervention testing · Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse

Autonomic symptoms improved more than in the comparison group.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on autonomic symptoms in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (61 in all)
  • Effect size 1.17 (large)

How big was the difference?

1.17, large. The effect size compares Graded exercise therapy (GET) with relaxation/flexibility group.

See the 1 study
  1. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    resting systolic BP
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    Low
    Selection of the reported result
    Some concerns
Cognition (brain fog)1 study · 32 people took part in Graded exercise therapy (GET) Improvement C
Very low certainty

Why this grade: Improvement, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (61 in all).

The randomised trial68 randomised · 61 started · 61 analysed · 4 weeks' post-intervention testing · Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse

Cognition (brain fog) improved more than in the comparison group.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on cognition (brain fog) in ME/CFS. Improvement · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (61 in all)
See the 1 study
  1. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    modified Stroop Colour Word test
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
Pain2 studies · 247 people took part in Graded exercise therapy (GET) Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; no confidence interval shows an important benefit is ruled out.

Randomised trials2 studies · 842 people with results

No clear difference in pain.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on pain in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • No confidence interval shows an important benefit is ruled out
See the 2 studies
  1. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. (2024)

    People in the study
    241 randomised · 201 analysed
    Dose
    slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call
    Outcome
    visual analogue pain scale visual analogue scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial. (2014)

    People in the study
    641 randomised
    Dose
    —
    Outcome
    Joint pain
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    High
Depression2 studies · 12 people took part in Graded exercise therapy (GET) Uncertain –
Very low certainty

Why this grade: Uncertain, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; few people (24 in all); effect size 1.37 (large); helped less than hrv-bf, an active treatment; not a sign of harm.

The randomised trial28 randomised · 24 analysed · eight individual training sessions of 50 minutes each at weekly intervals · eight individual training sessions of 50 minutes each at weekly intervals

Depression improved less than with the comparison treatment.

Graded exercise therapy (GET) helped depression less than hrv-bf in the one comparison. Uncertain · very low certainty –

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • Few people (24 in all)
  • Effect size 1.37 (large)
  • Helped less than hrv-bf, an active treatment; not a sign of harm

How big was the difference?

1.37, large. The effect size compares Graded exercise therapy (GET) with hrv-bf.

Studies with no comparison group1 in the study · 26-session · daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions (few people)

Depression improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on depression in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (1 in all)
  • Not all results were tested against chance
See the 2 studies
  1. Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: An exploratory pilot study. (2017)

    People in the study
    28 randomised · 24 analysed
    Dose
    eight individual training sessions of 50 minutes each at weekly intervals
    Outcome
    depression between groups Patient Health Questionnaire (PHQ-9)
    Effect
    worse
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Does graded activity increase activity? A case study of chronic fatigue syndrome. (2002)

    People in the study
    1 in the study
    Dose
    daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions
    Outcome
    BAI and BDI scores Beck depression inventory
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Daily life and health overall

Daily functioning6 studies · 485 people took part in Graded exercise therapy (GET) Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; the studies disagree; randomised trials found mixed results.

Randomised trials4 studies · 1,005 people with results

Studies disagree about daily functioning.

Studies disagree about whether graded exercise therapy (GET) helps daily functioning. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Studies with no comparison group2 studies · 93 people with results

Daily functioning improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on daily functioning in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance

Combination: evidence based explanations of symptoms + Graded exercise therapy (GET) + educational information pack + seven planned telephone contacts + seven one hour face to face treatment se148 randomised

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. (2001): SF-36 physical functioning, better.

Shown, not counted: Graded exercise therapy (GET) was given together with other treatments.

See the 6 studies
  1. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial. (2024)

    People in the study
    241 randomised · 201 analysed
    Dose
    slowly increase (by 10–20% a week) their physical activity when they felt able to, 1:1 sessions, face-to-face or via video call
    Outcome
    SF-36 physical function subscale (SF-36-PFS) at 6 months (primary outcome) SF-36 physical function subscale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  2. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. (2017)

    People in the study
    211 randomised · 102 analysed
    Dose
    six-step graded exercise programme, up to four guidance sessions with a physiotherapist over 8 weeks (maximum 90 min in total)
    Outcome
    Physical function (SF-36 PF) at 12 weeks Short Form-36 physical function subscale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  3. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012) (clinically significant reduction in disability)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (impairment in daily activities (WSAS))

    People in the study
    641 randomised
    Dose
    —
    Outcome
    physical function (short form-36 subscale score) short form-36 physical function subscale
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  4. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    Activity levels Older Adult Exercise Status Inventory
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  5. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care - a benchmarking study. (2022)

    People in the study
    92 with outcome data
    Dose
    between 12 and 16, individual, one-hour sessions, generally once every two weeks
    Outcome
    Physical functioning Short-Form Health Survey
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  6. Does graded activity increase activity? A case study of chronic fatigue syndrome. (2002)

    People in the study
    1 in the study
    Dose
    daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions
    Outcome
    step counts
    Effect
    better (not tested)
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I
Quality of life3 studies · 180 people took part in Graded exercise therapy (GET) Mixed results C
Very low certainty

Why this grade: Mixed results, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; the studies disagree; randomised trials found mixed results.

Randomised trials2 studies · 594 people with results

Studies disagree about quality of life.

Studies disagree about whether graded exercise therapy (GET) helps quality of life. Mixed results · very low certainty C

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • The studies disagree

Studies with no comparison group26 with outcome data · before and after 12 weeks of GET

Quality of life improved.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on quality of life in ME/CFS. Improvement · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Few people (26 in all)
See the 3 studies
  1. Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: An exploratory pilot study. (2017)

    People in the study
    28 randomised · 24 analysed
    Dose
    eight individual training sessions of 50 minutes each at weekly intervals
    Outcome
    physical QoL Short Form General Health Survey (SF36)
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  2. Adaptive pacing, cognitive behaviour therapy, graded exercise, and specialist medical care for chronic fatigue syndrome: a cost-effectiveness analysis. (2012)

    People in the study
    641 randomised · 570 analysed
    Dose
    up to 15 individual therapy sessions
    Outcome
    Incremental effect quality-adjusted life years (QALYs)
    Effect
    better (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    High
    Deviations from intended interventions
    High
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  3. Influence of graded exercise therapy on anxiety levels and health-related quality of life in chronic fatigue syndrome. (2014)

    People in the study
    26 with outcome data
    Dose
    —
    Outcome
    SF-36 scores Medical Outcomes Study Short-Form questionnaire (SF-36)
    Effect
    better
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
Overall symptoms7 studies · 1,031 people took part in Graded exercise therapy (GET) Little or no difference D
Very low certainty

Why this grade: Little or no difference, very low certainty, from randomised trials: high risk of bias (RoB 2) in the results that carry most of the weight; no confidence interval shows an important benefit is ruled out; the studies disagree; effect size 0.00 (very small).

Randomised trials4 studies · 1,445 people with results

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on overall symptoms in ME/CFS. Little or no difference · very low certainty D

  • High risk of bias (RoB 2) in the results that carry most of the weight
  • No confidence interval shows an important benefit is ruled out
  • The studies disagree
  • Effect size 0.00 (very small)

How big was the difference?

0, very small. The effect size compares Graded exercise therapy (GET) with control group (smc alone).

Compared with another group, not randomised171 in the study · 148 with outcome data · Fourteen sessions; first 12 typically weekly or fortnightly; sessions 13 or 14 follow-up or booster · Fourteen sessions, the first 12 of these being typically weekly or fortnightly

No clear difference in overall symptoms.

The evidence is very uncertain about the effect of graded exercise therapy (GET) on overall symptoms in ME/CFS. Little or no difference · very low certainty D

  • Serious risk of bias (ROBINS-I)
  • The change wasn't shown to be more than chance

Studies with no comparison group2 studies · 56 people with results

Studies disagree about overall symptoms.

Studies disagree about whether graded exercise therapy (GET) helps overall symptoms. Mixed results · very low certainty C

  • No control group: part of any change may be placebo, natural recovery or regression to the mean (risk of bias by design)
  • Not all results were tested against chance
  • The studies disagree
See the 7 studies
  1. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. (2017)

    People in the study
    211 randomised · 102 analysed
    Dose
    six-step graded exercise programme, up to four guidance sessions with a physiotherapist over 8 weeks (maximum 90 min in total)
    Outcome
    CGI overall health positive change clinical global impression
    Effect
    better
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  2. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. (2011)

    Same trial, also reported in: Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial. (2015) (perceived health change (PCGI))

    Same trial, also reported in: Recovery from chronic fatigue syndrome after treatments given in the PACE trial. (2013) (Adjusted odds of trial recovery: GET v. SMC)

    People in the study
    641 randomised
    Dose
    —
    Outcome
    clinical global impression: much better or very much better in overall health clinical global impression scale
    Effect
    worse (not tested)
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    Low
  3. Randomised controlled trial of graded exercise in chronic fatigue syndrome. (2004)

    People in the study
    68 randomised · 61 started · 61 analysed
    Dose
    Initial exercise duration was between 5 and 15 minutes, and intensity was based on the mean HR value achieved mid-point during the submaximal exercise tests, Subjects were instructed to exercise every second day, unless they had a relapse
    Outcome
    Self-rated clinical global impression change scores after completing treatment global impression scale
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Low
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    High
    Measurement of the outcome
    High
    Selection of the reported result
    Some concerns
  4. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. (2018)

    People in the study
    641 randomised
    Dose
    up to 15 therapy sessions, over 36 weeks
    Outcome
    recovery rates
    Effect
    no clear difference
    Risk of bias
    RoB 2: High
    Randomisation process
    Some concerns
    Deviations from intended interventions
    Some concerns
    Missing outcome data
    Low
    Measurement of the outcome
    High
    Selection of the reported result
    High
  5. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome. (2016)

    People in the study
    171 in the study · 148 with outcome data
    Dose
    Fourteen sessions, the first 12 of these being typically weekly or fortnightly
    Outcome
    CBT vs GET effectiveness on fatigue, anxiety, depression, and physical functioning
    Effect
    no clear difference
    Risk of bias
    ROBINS-I: Serious
    Confounding
    Moderate. adjusted for: anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence change in anxiety, depression, beliefs concerning uncontrollability and danger of thoughts, and cognitive confidence covariates entered as fixed effects
    Selection of participants
    Moderate. comparison group: patient preference Patient preference drove choice of therapy
    Classification of interventions
    Low. assigned and recorded at the start
    Deviations from intended interventions
    NI. not reported for this design
    Missing data
    Moderate. missing data: Ten CBT patients and seven GET patients dropped out without agreement; three patients each from CBT and GET ended therapy with therapist consent; prorated by adding a mean score value for missing items if a maximum of two scores were missing; data withdrawn if no consent at all three data points Ten CBT patients and seven GET patients dropped out of therapy without first agreeing to do so with their therapist. Three patients each from CBT and GET ended therapy with the consent of their therapist.
    Measurement of outcomes
    Serious. self-reported by people who knew their treatment
    Selection of the reported result
    NI. whether this outcome was pre-specified isn't reported
  6. Graded Exercise Therapy for Chronic Fatigue Syndrome (2001)

    People in the study
    59 in the study · 55 started · 55 with outcome data
    Dose
    patients usually attended every fortnight; double session of 40 minutes on average
    Outcome
    therapist scored CGI ratings Clinical Global Impression (CGI) change score
    Effect
    better (not tested)
    Risk of bias
    before-after study without a control group (JBI checklist for quasi-experimental studies); not rated with RoB 2 or ROBINS-I
  7. Does graded activity increase activity? A case study of chronic fatigue syndrome. (2002)

    People in the study
    1 in the study
    Dose
    daily 10-min walks and progressed, in 5-min increments as tolerance increased, to 40-min daily walks by session 14, The first 13 sessions were scheduled once-a-week, followed by four biweekly sessions, then, three tri-weekly sessions, and finally six monthly sessions
    Outcome
    symptom criteria for CFS
    Effect
    no clear difference
    Risk of bias
    case report or series (JBI checklist for case reports / case series); not rated with RoB 2 or ROBINS-I

Studies of combinations

Outcomes that only studies of Graded exercise therapy (GET) given together with other treatments looked at. Shown, not graded: they can’t tell what Graded exercise therapy (GET) did alone.

Sleep ME/CFS

Combination: evidence based explanations of symptoms + Graded exercise therapy (GET) + educational information pack + seven planned telephone contacts + seven one hour face to face treatment se148 randomised

Randomised controlled trial of patient education to encourage graded exercise in chronic fatigue syndrome. (2001): sleep problem questionnaire, better.

Shown, not counted: Graded exercise therapy (GET) was given together with other treatments.

Side effects

Stopping because of side effects4 studies
Side effects studies reported2 kinds
Side effects studies reported, and how many studies reported each
Side effectStudies that reported it
Worse symptoms or a flare4 studies
Fatigue2 studies

Systematic reviews

Reviews pool earlier studies. Each shows when it was published and how far its search went.

All papers

  1. Graded exercise therapy compared to activity management for paediatric chronic fatigue syndrome/myalgic encephalomyelitis: pragmatic randomized controlled trial.2024 · randomised trial · 241 randomised · 201 analysed
    Summary

    MAGENTA was a pragmatic parallel group randomized controlled trial comparing graded exercise therapy (GET) with activity management (AM) in children aged 8-17 years with mild/moderate ME/CFS presenting to NHS specialist paediatric services. It randomly allocated 241 children (60% of eligible patients): 123 to GET and 118 to AM. GET was delivered by specialist therapists as a personalised approach, with physical activity increased by 10–20% a week when participants felt able; AM was a personalised approach to cognitive, school and social activity. Sessions were 1:1, face-to-face or via video call, over 12 months of follow-up. The primary outcome was the SF-36 physical function subscale at 6 months. Data were available for 201 (83%) participants, who received a mean of 3.9 (GET) or 4.6 (AM) treatment sessions. Mean SF-36-PFS changed from 54.8 (SD 23.7) to 55.7 (23.3) for GET and from 55.5 (23.1) to 57.7 (26.0) for AM, with an adjusted difference in means of −2.02 (95% CI −7.75 to 3.70), p = 0.49. At 12 months, 135 participants completed the mean SF-36-PFS; the difference was 3.15 (95% CI −4.20 to 10.51), p = 0.40. Deterioration from at least one measure occurred in 33 out of 123 (27%) GET and 20 out of 117 (17%) AM participants (p = 0.069). Five participants withdrew from allocated therapy due to feeling worse: four of 117 (3%) in GET and 1/123 (1%) in AM. Four serious adverse events requiring hospital treatment were reported; one serious adverse event was possibly related to GET, a psychiatric hospital admission due to suicidal ideation.

  2. Guided graded exercise self-help for chronic fatigue syndrome: Long term follow up and cost-effectiveness following the GETSET trial.2021 · randomised trial · 211 randomised · 158 analysed
    Summary

    This long-term follow-up and cost-effectiveness study of the GETSET trial asked whether guided graded exercise self-help (GES) added to specialist medical care (SMC) had longer-term effects in adults with chronic fatigue syndrome (CFS) attending two UK NHS secondary care clinics. The trial randomised 211 participants (104 to SMC alone, 107 to SMC plus GES). GES was a self-help booklet plus up to four Skype/telephone guidance sessions (first could be face-to-face), totalling 90 minutes over 8 weeks. The comparison was SMC alone. Primary outcomes were the Chalder fatigue questionnaire (CFQ) and SF-36 physical functioning (SF-36 PF); follow-up was a median 15 months (IQR 13-19) after randomisation. Questionnaires were returned by 164 (78%); primary analyses included 158 (GES 77, SMC 81). After Bonferroni correction, the paper reported no main effect of arm on fatigue (chi2(1)=4.8, p=0.03) or functioning (chi2(1)=1.3, p=0.25). The arm*time interaction was just significant for CFQ (chi2(1)=5.0, p=0.0247) but not SF-36 PF (chi2(1)=1.4, p=0.23). No side-effect counts were reported; deterioration was measured with CGI change scores: CGI-Health negative change was 7 (9%) GES vs 5 (6%) SMC, and CGI-CFS 4 (5%) vs 6 (8%), with no main effect of arm. One (<1%) participant withdrew consent. Over long-term follow-up, mean costs were £1,552 for GES and £1,524 for SMC; adjusted costs were £85 higher with GES. QALYs were 0.5911 vs 0.5812 (difference 0.0177); ICER was £4802 per QALY, with a 63% likelihood of being most cost-effective at £20,000 per QALY.

  3. Results of the feasibility phase of the managed activity graded exercise in teenagers and pre-adolescents (MAGENTA) randomised controlled trial of treatments for chronic fatigue syndrome/myalgic encephalomyelitis.2019 · randomised trial · 80 randomised
    Summary

    This feasibility study asked whether a randomised trial comparing graded exercise therapy (GET) with activity management was practical and acceptable for young people with mild to moderate CFS/ME. Eighty young people were enrolled across three NHS paediatric CFS/ME services; 40 were allocated to GET and 40 to activity management. Both treatments were delivered face-to-face or by Skype, typically in 8–12 sessions every 2–6 weeks; treatment duration was not reported. Follow-up was at baseline, six and 12 months. The study measured recruitment, retention, acceptability, fidelity and accelerometer use, not treatment effects. All 80 participants started their allocated treatment. Three out of 40 in the activity management arm (7.5%) and three out of 40 in the GET arm (7.5%) discontinued treatment early. One participant in the activity management arm crossed over to GET after six months. Mean appointments attended at one centre were similar: activity management 9.7 (4.7), n = 37, and GET 9.6 (4.5), n = 39. The 6-month primary outcome was completed by 91.4% (32). Qualitative feedback supported acceptability of both arms; most reported feeling less tired generally, and parents and participants noted activity management had a beneficial effect. The authors report a low rate of adverse events, similar in each arm, with no counts. One reason for stopping was deteriorating in the allocated arm (1); three participants withdrew from research follow-up for unknown reasons.

  4. Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT.2018 · randomised trial · 641 randomised
    Summary

    This reanalysis used the PACE trial FOIA dataset. Participants were 641 adults with mild-to-moderate CFS defined by the Oxford criteria, randomised into four groups. All were offered at least three medical consultations. Control received no further treatment; CBT, GET, and Adaptive Pacing Therapy each received up to 15 therapy sessions over 36 weeks. At 52 weeks, protocol-specified overall improvement was 20% for CBT, 21% for GET, and 10% for Control. The CBT–Control contrast had p = .015 and the GET–Control contrast p = .010; with the six planned comparisons, the Bonferroni-adjusted threshold was 0.008, and neither comparison reached it. Available-case improvement was 22% CBT, 21% GET, and 11% Control. Protocol-defined recovery was 7% CBT, 4% GET, and 3% Control; the effect was not significant (p = 0.14 intent-to-treat; p = 0.10 available case). SF36 physical-function improvement was 44% Control, 48% CBT, and 61% GET. CFQ improvement was 13% Control, 26% CBT, and 24% GET. Long-term follow-up excluding patients who received additional GET or CBT found no significant treatment-group effect on SF-36 Physical Function (F(3,291) = 0.70, ns) or Chalder Fatigue (F(3,291) = 0.17, ns). Adverse-event measures were collected; the extracted data contain no event counts.

  5. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial.2017 · randomised trial · 211 randomised · 102 analysed
    Summary

    GETSET was an open-label randomised trial at two UK NHS secondary-care clinics in London and Kent. It enrolled 211 adults with chronic fatigue syndrome by NICE criteria who were on a waiting list for therapy; 107 were assigned to guided graded exercise self-help (GES) plus specialist medical care and 104 to specialist medical care alone. GES was a self-help booklet describing a six-step graded exercise programme taking roughly 12 weeks, with up to four physiotherapist guidance sessions over 8 weeks (maximum 90 min in total). The control group received specialist medical care alone. At 12 weeks, 97 GES and 102 control participants were analysed. Mean fatigue score (CFQ) was 19·1 in the GES group and 22·9 in the control group (adjusted difference −4·2, 95% CI −6·1 to −2·3, p<0·0001). Mean physical function score (SF-36 PF) was 55·7 versus 50·8 (adjusted difference 6·3, 1·8 to 10·8, p=0·006). More GES participants improved by at least 3 CFQ points (62 [64%] versus 45 [44%]) and at least 8 SF-36 PF points (44 [45%] versus 22 [22%]). Non-serious adverse events were reported by 27 (28%) GES and 23 (23%) control participants; serious adverse events by 1 (1%) and 2 (2%); serious adverse reactions by 0 in both groups. Serious deterioration was 20 (21%) versus 30 (30%). Withdrawal due to worsening was 0 in both groups; two (2%) GES participants and none in the control group actively withdrew from the intervention. Ten (9%) GES and two (2%) control participants were lost to follow-up.

  6. Heart rate variability biofeedback therapy and graded exercise training in management of chronic fatigue syndrome: An exploratory pilot study.2017 · randomised trial · 28 randomised · 24 analysed
    Summary

    This exploratory pilot study examined heart rate variability biofeedback therapy (HRV-BF) and graded exercise training (GET) for fatigue, quality of life and depression in women with chronic fatigue syndrome (CFS). Participants were recruited through newspaper advertisements and an Internet web page and treated in an outpatient setting in Germany. A total of 28 women with CFS were randomly assigned; 24 patients were analysed (13 HRV-BF, 11 GET). Both treatments consisted of eight training sessions of 50 minutes at weekly intervals, with a five-month follow-up. General fatigue improved significantly after both HRV-BF and GET. After HRV-BF, fatigue scores improved significantly in all subscales except reduced motivation; after GET, general fatigue improved significantly. There were no significant differences between groups in fatigue. Physical quality of life improved significantly after GET, whereas HRV-BF showed no significant improvement on this subscale. Mental quality of life improved significantly after HRV-BF, but not after GET. Depression reduced significantly after HRV-BF, while GET had no effect on depression. Between groups, there were significant differences in mental quality of life and depression favouring HRV-BF, and no significant difference in physical quality of life. In the GET group, four patients dropped out and terminated therapy prematurely; all four noted a lack of benefit as the reason for quitting. Negative changes included a change in daily routines and role perception, an increase in migraines, a gain in appetite and in weight, stressful conversations, and a depressive episode in GET. Authors state the small sample size as a limitation.

  7. Intermittent and graded exercise effects on NK cell degranulation markers LAMP-1/LAMP-2 and CD8+CD38+ in chronic fatigue syndrome/myalgic encephalomyelitis.2017 · randomised trial · 24 randomised
    Summary

    This 12‐week pilot randomized controlled trial asked whether graded exercise (GE) or intermittent exercise (IE) changed cytotoxic lymphocyte markers in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Twenty‐four CFS/ME participants were randomized to GE, IE, or usual care (UC); 18 matched sedentary non‐CFS/ME participants formed a control group (CTL). Each exercise arm had 8 participants, UC had 8, and CTL had 18. GE and IE were cycling sessions three sessions a week for 12 weeks; UC received rest and lifestyle advice. Outcomes included stimulated CD3+CD8+CD38+ and NK cell LAMP‐1/LAMP‐2 expression and aerobic exercise capacity. The paper reports that NK cell LAMP‐1/LAMP‐2 expression increased pre‐to‐postintervention for GE and IE, while neither GE nor IE had a significant effect on CD8+CD38+ expression. V̇O2peak increased significantly in IE (P = 0.027 ES: 0.7) and GE (P = 0.048 ES: 0.6). Elapsed test time and V̇ Epeak increased significantly in IE (P = 0.034 ES: 0.6; P = 0.004 ES: 0.6). GE showed trends to increase in V̇ Epeak (P = 0.075 ES: 0.6) and RERpeak (P = 0.060 ES: 0.5). The authors state both GE and IE improved exercise capacity without worsening CFS/ME symptoms. Side-effect counts and withdrawals were not reported. The authors state the pilot cohort was small and gender data were pooled in each group.

  8. Graded versus Intermittent Exercise Effects on Lymphocytes in Chronic Fatigue Syndrome.2016 · randomised trial · 24 randomised
    Summary

    This randomised controlled pilot trial asked whether 12 weeks of graded exercise (GE) or intermittent exercise (IE) on a cycle ergometer changes immune measures, aerobic capacity and fatigue in CFS. 24 CFS patients were randomised to GE, IE or usual care (rest and lifestyle advice), with 8 per group; 18 sedentary non-CFS participants were controls and were asked to maintain their current activity. Exercise was supervised three times per week. GE used a load equivalent to 50% O2peak, RPE 3; IE alternated one minute at 60% O2peak, RPE 4-5 with one minute at 30% O2peak, RPE 1-2. Outcomes included O2peak, full blood counts, circulating lymphocyte subsets, PHA-stimulated CD4+, CD25+ and CD134+ expression, and fatigue severity. O2peak increased in GE (P = 0.048, ES 0.6) and IE (P = 0.027, ES 0.7). Elapsed test time and Epeak increased in IE (P = 0.034, ES 0.6; P = 0.004, ES 0.6); GE showed trends for Epeak (P = 0.075, ES 0.6) and RERpeak (P = 0.060, ES 0.5). Post-intervention fatigue severity did not differ between GE, IE and usual care (P = 0.75). Two GE participants and one usual-care participant withdrew due to time constraints. Three participants mentioned fatigue, joint pain or illness affecting exercise; the authors state symptoms were not due to exercise demands. The paper reports no exacerbation of CFS symptoms. Compliance was 89%.

  9. The planning, implementation and publication of a complex intervention trial for chronic fatigue syndrome: the PACE trial.2015 · randomised trial · 640 randomised
    Summary

    The PACE trial was a four-arm randomised trial in 640 patients with chronic fatigue syndrome recruited from six clinics in England and Scotland. It compared specialist medical care (SMC) alone with SMC plus adaptive pacing therapy (APT), cognitive–behavioural therapy (CBT), or graded exercise therapy (GET). Treatment duration was not reported. Co-primary outcomes were fatigue and physical disability; outcomes were assessed at baseline, mid-therapy, the end of the main treatment phase, 1-year follow-up and long-term follow-up 2.5 years after randomisation. CBT and GET led to significantly greater improvements in both fatigue and physical disability than either SMC or APT. Adjusted effect sizes ranged from 0.5 to 0.8. There were no significant differences between APT and SMC in either primary outcome. Almost all participants (98%) provided some outcome data, and 95% provided outcome data at 12 months, with no significant differences between arms in missing data. Only 8% of participants dropped out of treatment, again with no significant difference between treatment arms. Between 82 and 88% of participants who received a therapy alongside SMC said they were satisfied, whereas 50% reported being satisfied with SMC alone. There were no significant differences in any safety measures between treatment arms. The cost of one quality-adjusted life-year (QUALY) gained was £18 374 for CBT and £23 615 for GET. The authors state that having two primary outcomes complicated the analysis, although the size of the trial gave sufficient power.

  10. Rehabilitative treatments for chronic fatigue syndrome: long-term follow-up from the PACE trial.2015 · randomised trial · 641 randomised · 604 started · 481 analysed
    Summary

    This long-term follow-up of the PACE trial surveyed participants with chronic fatigue syndrome (CFS) recruited from six secondary care clinics in the United Kingdom. In the trial, 641 participants were randomly allocated to specialist medical care (SMC) alone or SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), given in one-to-one sessions (maximum 14 sessions) during the first six months, with an additional booster session offered at nine months. Questionnaires were sent to 604 participants; 481/604 (80%) returned usable questionnaires and were included in the analysis. Median time from randomisation to follow-up was 31 months (range 24 to 53 months). Fatigue and physical functioning were measured with self-report scales, with secondary measures of impairment in daily activities and perceived health change. The improvements in fatigue and physical functioning reported by participants allocated to CBT or GET at the final trial assessment were sustained. There were no significant differences between randomised groups in mean fatigue scores at long-term follow-up. Physical functioning was better in those allocated to CBT compared with APT (6.4, 95% CI 0.4 to 12.4, p = 0.035). Participants originally allocated to APT reported further improvements in fatigue, physical functioning, and impairment in daily activities from final trial assessment to long-term follow-up. The authors state limitations including incomplete response rate, variation in follow-up duration, self-rated outcomes, and additional treatment after the trial.

  11. Pain in chronic fatigue syndrome: response to rehabilitative treatments in the PACE trial.2014 · randomised trial · 641 randomised
    Summary

    To compare the effects of PACE trial treatments on pain in CFS, sometimes called ME. In total, 641 patients were recruited from secondary-care specialist CFS clinics in the UK. APT (n=159), CBT (n=161) and GET (n=160) were each added to specialist medical care (SMC) and compared with SMC alone (n=160); treatment duration was not reported, and measures were assessed at week 52. Outcomes included frequency of muscle and joint pain (0–4), other CDC painful symptoms, and fibromyalgia criteria. Less frequent muscle pain was reported with CBT versus SMC (mean difference 0.38, p=0.02), GET versus SMC (0.42, p=0.01), and GET versus APT (0.37, p=0.01). Less joint pain was reported with CBT versus APT (0.35, p=0.02) and GET versus APT (0.36, p=0.02); unadjusted joint-pain comparisons with SMC were p=0.14 for CBT and p=0.12 for GET. GET versus SMC reduced fibromyalgia (12.3% difference, p=0.01), and GET versus APT reduced fibromyalgia (9.4% difference, p=0.04). One participant withdrew consent; dropouts were 5%. Harms were not reported. The authors state they could not compare CBT and GET and that pain was measured by frequency, not severity; the hospital-based sample may affect generalisability.

  12. Adverse events and deterioration reported by participants in the PACE trial of therapies for chronic fatigue syndrome.2014 · randomised trial · 641 randomised · 640 analysed
    Summary

    This four-arm randomised trial compared specialist medical care (SMC) alone with SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET) in 641 people with chronic fatigue syndrome (CFS) recruited from six secondary care CFS clinics in England and Scotland. Participants received up to 15 sessions of therapy if allocated to a therapy arm and at least 3 sessions of SMC; follow-up was up to one year, with adverse-event interviews at 12, 24 and 52 weeks after randomisation. One participant withdrew consent, leaving 640 in the analysis. Non-serious adverse events were common: the median (quartiles) number was 4 (2, 8) per participant, with no significant difference between treatment arms (P = .47). Serious adverse events and reactions were infrequent. Physical function deteriorated in 39 (25%) participants after APT, 15 (9%) after CBT, 18 (11%) after GET, and 28 (18%) after SMC (P < .001), with no significant differences in worsening fatigue. The authors also reported no statistically significant differences between arms in those who had an SAE, SAR, or deterioration by CGI score. Limitations included differences in NSAE reporting frequency between centres, self-rated deterioration measures, and inability to model the full distribution of NSAEs.

  13. Recovery from chronic fatigue syndrome after treatments given in the PACE trial.2013 · randomised trial · 641 randomised · 640 started · 640 analysed
    Summary

    This secondary analysis of the PACE trial compared recovery after four treatments in 641 participants recruited from six secondary care CFS clinics in England and Scotland; 640 were studied. All met Oxford criteria for CFS. Participants received specialist medical care (SMC) alone or SMC plus adaptive pacing therapy (APT), cognitive behaviour therapy (CBT), or graded exercise therapy (GET), with follow-up 52 weeks after randomization. Recovery was defined operationally using fatigue, physical function, case criteria and global change measures. Trial recovery was 22% (32/143) after CBT, 22% (32/143) after GET, 8% (12/149) after APT and 7% (11/150) after SMC. Clinical recovery proportions were similar. Adjusted odds ratios for trial recovery were 3.36 (1.64–6.88) for CBT v. APT, 3.38 (1.65–6.93) for GET v. APT, 3.69 (1.77–7.69) for CBT v. SMC and 3.71 (1.78–7.74) for GET v. SMC; APT v. SMC was 1.10 (0.47–2.58), with no significant difference. The number needed to treat for trial recovery was 7 for both CBT and GET. Some data were missing for 6% of those receiving APT and SMC and 11% for those receiving CBT and GET. Side effects and withdrawals were not reported.

  14. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial.2011 · randomised trial · 641 randomised
    Summary

    This randomised trial enrolled 641 patients meeting Oxford criteria for chronic fatigue syndrome from six secondary-care clinics in the UK. Participants were assigned to specialist medical care (SMC) alone (160), or SMC plus adaptive pacing therapy (APT; 160), cognitive behaviour therapy (CBT; 161), or graded exercise therapy (GET; 160). Outcomes were assessed up to 52 weeks after randomisation. Primary outcomes were participant-rated fatigue (Chalder fatigue questionnaire) and physical function (short form-36 subscale). Compared with SMC alone, mean fatigue scores at 52 weeks were 3·4 points lower for CBT (p=0·0001) and 3·2 points lower for GET (p=0·0003), but did not differ for APT (0·7 points lower; p=0·38). Mean physical function scores were 7·1 points higher for CBT (p=0·0068) and 9·4 points higher for GET (p=0·0005), but did not differ for APT (3·4 points lower; p=0·18). Compared with APT, CBT and GET were associated with less fatigue (CBT p=0·0027; GET p=0·0059) and better physical function (CBT p=0·0002; GET p<0·0001). Serious adverse reactions were recorded in two (1%) of 159 in APT, three (2%) of 161 in CBT, two (1%) of 160 in GET, and two (1%) of 160 in SMC alone. There were more serious adverse events in GET than SMC (p=0·0433); treatment dropouts did not differ (p=0·50). A minority (≤9% in every group) rated themselves much worse or very much worse, which did not differ between groups.

  15. Graduated exercise training and progressive resistance training in adolescents with chronic fatigue syndrome: a randomized controlled pilot study.2010 · randomised trial · 22 randomised · 11 analysed
    Summary

    Twenty-two adolescents with chronic fatigue syndrome admitted to an inpatient rehabilitation programme were randomized to either graded aerobic exercise training (n=11) or progressive resistance training (n=11) for five days/week for four weeks. The aerobic training consisted of 20–40 minutes of stationary cycling and treadmill exercise; resistance training involved 16 exercises with single set, moderate load and high repetitions. Exercise tolerance (time to fatigue, metabolic equivalents), quality of life (SF-36 physical component score), muscular strength (push-ups) and endurance (sit-to-stand), fatigue severity (Fatigue Severity Scale) and depressive symptoms (Beck Depression Index) were measured before and after the four-week intervention. No significant between-group differences were found for any outcome. Within groups, time to fatigue improved significantly in the aerobic group (P2=0.008) but not in the resistance group (P2=0.1); metabolic equivalents improved significantly in the aerobic group (P2=0.03) and not significantly in the resistance group (P2=0.08). Sit-to-stand, SF-36 PCS and Beck Depression Index improved significantly in both groups. Fatigue severity improved significantly only in the aerobic group (P2=0.001) and not in the resistance group (P2>0.05). One participant in the resistance group had an injury restricting ability to complete the intervention, and withdrawals were 1 in the aerobic group and 2 in the resistance group. The authors state that both interventions were well tolerated with no adverse events recorded.

  16. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change.2005 · randomised trial · 49 randomised
    Summary

    This randomized controlled trial enrolled 49 adults meeting CDC criteria for CFS from a specialist CFS private general practice in Auckland, New Zealand. Patients were randomized to a 12-week graded exercise programme (25 patients) or standard medical care (24 patients). The exercise group had weekly meetings and a target heart rate initially set at 40 per cent of VO2max for 10–15 minutes 4 to 5 times a week; both groups received standard medical care. Outcomes included self-rated global improvement, fatigue on the 14-item Fatigue Scale, SF-36 physical functioning, symptom focus, illness beliefs and fitness measures. At 12 weeks, 12 of 22 exercise completers rated themselves much or very much better versus 5 of 21 controls (p = .04); intention-to-treat figures were 48 per cent versus 21 per cent. The exercise group scored lower on physical, mental and total fatigue, and lower on symptom focus, but there was no significant group effect on SF-36 physical functioning, treatment control, personal control, illness identity, maximum HR, percentage predicted maximum HR or VO2 peak. At six months, 54 per cent of the exercise group versus 28 per cent of controls rated themselves better. Three of 25 exercise patients dropped out and 3 of 24 controls did not return 12-week questionnaires; one exercise patient injured his calf and stopped. The authors state the sample was smaller than anticipated.

  17. Randomised controlled trial of graded exercise in chronic fatigue syndrome.2004 · randomised trial · 68 randomised · 61 started · 61 analysed
    Summary

    This randomised controlled trial asked whether 12 weeks of graded exercise with pacing would improve physiological, psychological and cognitive functions in chronic fatigue syndrome. Sixty-eight patients were randomised; 61 were analysed (32 graded exercise, 29 relaxation/flexibility), aged 16–74 years, recruited through notices in medical surgeries and local newspaper advertisements, with CFS diagnosed by Fukuda criteria. The graded exercise group used walking, cycling or swimming, starting at 5–15 minutes and based on heart rate; the comparison group listened to a relaxation tape and performed stretching exercises, also over 12 weeks. Outcomes included resting blood pressure and heart rate, work capacity, oxygen uptake, blood lactate, perceived exertion, activity levels, fatigue, anxiety, depression, Stroop test performance and a global impression rating. The text reports improvements after graded exercise for resting systolic BP (P=0.018), work capacity (P=0.019), net blood lactate production (P=0.036), depression (P=0.027), the more difficult Stroop level (P=0.029) and lower perceived exertion (P=0.013). It states no such changes in the relaxation/flexibility condition. Oxygen uptake difference in final values was not significant; activity levels rose but final levels did not differ. On global impression, 29/32 exercise and 22/29 relaxation participants rated themselves better, with no significant between-group difference (χ2=1.46; P=0.227). The text reports no relapse in any participant and no subject felt graded exercise worsened symptoms; 2 exercise and 5 relaxation/flexibility subjects withdrew. Authors state limits include the control group and lack of blinding.

  18. Is graded exercise better than cognitive behaviour therapy for fatigue? A UK randomized trial in primary care.2004 · randomised trial
    Summary

    This was a randomized trial followed by a prospective cohort study in 22 general practices in London and South East England. GPs referred 144 patients aged 16 to 75 years with unexplained fatigue of >3 months for the therapy trial; 123 were randomized to CBT (N=63) or GET (N=60). A further 40 patients received a booklet plus usual care (BUC) in the prospective cohort. Only 36 (29%) conformed to CDC criteria for CFS. Treatment was six 45-min sessions over 12 weeks. The primary outcome was fatigue on a Likert scale (maximum score 33), with assessments at baseline and at 3 and 8 months. Intention-to-treat data were available for 117/123 patients, 59/63 in CBT and 58/60 in GET; full data were available for 31/40 BUC patients. Mean fatigue scores at outcome combining 3 and 8 month data were 13.9 (S.D.=7.0) in CBT and 15.1 (S.D.=8.1) in GET; after adjustment the mean difference was x1.3 (CI=x3.9to1.3), with no significant difference between groups. Recovery by Chalder criteria was 30/59 (51%) following CBT and 28/58 (48%) following GET; by Cleare criteria it was 30/59 (51%) and 33/58 (57%). At outcome one-half of patients had clinically important fatigue in both randomized groups, but patients in the group offered CBT were less anxious. Two patients died before outcome; one suicide occurred in a patient allocated CBT who received four sessions. Individual fatigue scores increased in 2/59 (3%) receiving CBT and 7/58 (12%) receiving GET.

  19. Predictors of response to treatment for chronic fatigue syndrome.2002 · randomised trial · 114 randomised · 95 analysed
    Summary

    This was a predictor analysis within a randomised, controlled trial of a brief psychological intervention for chronic fatigue syndrome (Oxford criteria). Participants were 114 patients recruited from a chronic fatigue clinic and an infectious diseases out-patient clinic; outcome data were available for 95. The intervention taught evidence-based physiological explanations and encouraged a home-based graded exercise programme, given as three dosages: minimum (two individual sessions and two telephone follow-up calls plus helpline access), telephone (additional seven planned follow-up calls), and maximum (additional seven face-to-face sessions over 4 months). A no-treatment control group of 34 patients was not included in this study. Outcomes included change on the SF36 physical functioning scale and the London Handicap Scale at 1-year follow-up. The average improvement on SF36 physical functioning was 8.83 points (s.d. 5.23). Clinically significant improvement occurred in 26 of 37 minimum, 27 of 39 telephone and 26 of 38 maximum intervention patients; no significant difference was found between the three dosages. Poor response was predicted by dysphoria, self-help group membership and receipt of sickness benefit. Seventeen per cent of patients were lost to follow-up.

  20. Treatment Outcome and Metacognitive Change in CBT and GET for Chronic Fatigue Syndrome.2016 · compared with another group · 171 in the study · 148 with outcome data
  21. Why patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis improve or deteriorate with graded exercise therapy2016 · compared with another group
    Summary

    This qualitative, one-to-one interview study was situated within the GETSET Trial. A sub-sample of patients was stratified into improved and deteriorated and recruited: 9 were better and 10 were worse according to the Clinical Global Impression (CGI) scale. Participants discussed graded exercise therapy (GET). Participants generally found GET challenging, especially during initiation, as they had to wait considerable time for any benefit. The deteriorated group reported more barriers to GET, including a worse exacerbation of symptoms in response to GET, which interfered with life commitments such as work and caring duties. They also reported greater interference with GET from comorbid conditions and other things happening in their lives. The improved group reported more facilitators to doing GET, such as using other therapies, and were more likely to report exceptionally high levels of motivation. The paper does not report withdrawals in relation to harms. The authors conclude that the findings point to conditions under which GET is most likely to work and how health professionals could assist patients to benefit from GET. Limitations are not reported.

  22. Patient-reported treatment outcomes in ME/CFS and long COVID.2025 · no comparison group · 5,451 in the study · 3,925 with outcome data
  23. Graded exercise therapy for patients with chronic fatigue syndrome in secondary care - a benchmarking study.2022 · no comparison group · 92 with outcome data
    Summary

    This prospective audit/benchmarking study examined graded exercise therapy (GET) in a specialist CFS/ME service in south London. Data came from patients first seen in the service; 92 CFS/ME patients offered GET were analysed. GET was offered as between 12 and 16 individual, one-hour sessions, generally once every two weeks, with 3 months follow-up. There was no comparison group; outcomes were compared with randomised controlled trials through benchmarking. Measures included the Chalder Fatigue Questionnaire, Work and Social Adjustment Scale, SF-36 physical functioning subscale and Hospital Anxiety and Depression Scale. Fatigue scores were reduced by session 4 (–5.18) and at follow-up (–4.73). WSAS was reduced by discharge (–5.42) and at follow-up (–4.97). SF-36 physical functioning improved at discharge (9.63) and follow-up (10.75). Depression showed a significant decrease over time, but paired tests found no differences from pre-treatment to discharge (–1.52) or follow-up (–0.92); anxiety showed no effect of time. One patient discontinued after 11 sessions because they felt GET was “not suitable for them”; no other adverse events were reported. The authors state limitations including no controlled comparison group and non-randomised, non-blind assessment.

  24. Guided graded Exercise Self-help for chronic fatigue syndrome: patient experiences and perceptions.2020 · no comparison group · 19 in the study
    Summary

    This qualitative interview study was nested in the GETSET trial. It asked 19 people with CFS/ME from two NHS specialist clinics in southern England about their experiences of Guided graded Exercise Self-help (GES). All had specialist medical care; GES was a six-step self-help booklet followed over approximately 12 weeks, with up to four physiotherapist support sessions over 8 weeks. Interviews took place three to 26 months after GES, median 22 months. Participants were selected by Clinical Global Impression change ratings: nine reported feeling “much better” and 10 “a little worse”. The study compared these interview groups, not GES with another treatment. Analysis was thematic. The “much better” group described more facilitators to GES and high self-motivation; the “a little worse” group described more barriers, including worse symptom exacerbation after GES, more interference from comorbid conditions, obstacles in their lives, and longer illness. An “indeterminate phase” was identified early, when participants did not initially improve. A number of participants in both groups reported symptom exacerbation during GES, particularly pain and fatigue; for some this interfered with everyday life. Two participants in the “a little worse” group described “false starts”, and none in the “much better” group did. Half of the “a little worse” group reported discontinuing GES activities during or at the end of the programme; one was advised to discontinue after a physical reaction. The authors state limits including a sample of 19 from 32 invited, unblinded analysis, possible recall bias, and that this was GES, not therapist-delivered GET.

  25. The Impact of a Structured Exercise Programme upon Cognitive Function in Chronic Fatigue Syndrome Patients.2019 · no comparison group · 92 in the study · 53 started · 34 with outcome data
    Summary

    This nonrandomised study without a comparison group examined whether a structured exercise programme (SEP) affected cognitive function in people with ME/CFS. Of 1400 patients assessed, 1308 were excluded and 92 were enrolled; 53 underwent a 16-week SEP and 34 completed the intervention (64.2%). SEP was home exercise prescribed at least five days a week for 16 weeks, starting at 30–40% of HRmax, with the first 3 sessions lasting approximately 10 min; walking was the main exercise. Cognitive function was measured with SRT, CRT, VAT and DMS before and after SEP. The third SRT attempt reaction time for correct answers was 556.24 ms before vs 504.15 after (p = 0.045). VAT correct answers were 53.77 before vs 55.47 after (p = 0.007), VAT errors 6.68 vs 4.68 (p = 0.004), and VAT reaction time 1561.94 ms vs 1473.03 (p = 0.02). No significant changes were observed for other cognitive tests, and none of the statistically significant results survived FDR correction. The authors report a substantial number unwilling or unable to complete the programme; 35 from 69 patients did not complete the SEP programme. Side effects were not reported.

  26. Influence of graded exercise therapy on anxiety levels and health-related quality of life in chronic fatigue syndrome.2014 · no comparison group · 26 with outcome data
    Summary

    This study asked whether graed exercise therapy (GET) improves health-related quality of life (HRQOL) and anxiety in people with chronic fatigue syndrome (CFS), and whether HRQOL and anxiety scores correlate. Anxiety and HRQOL were assessed in 26 CFS patients before and after 12 weeks of GET, using the State-Trait Anxiety Inventory questionnaire (STAI) and the Medical Outcomes Study Short-Form questionnaire (SF-36). There was no comparison group; the design was not reported as randomised. GET significantly decreased trait anxiety (STAI-T) levels. SF-36 scores after GET showed higher levels of functioning, but only the "vitality" subscale scores showed a statistically significant difference. A negative correlation was present between all eight subscales of SF-36 and anxiety levels. The abstract does not report side effects, withdrawals, or a harms observation period. The authors conclude that GET has a positive effect on both physical and psychological state of CFS patients, that GET can decrease anxiety and improve quality of life, and that CFS patients with higher state and trait anxiety levels have lower quality of life, and vice versa. Limitations are not reported in the abstract.

  27. Use of an online survey to explore positive and negative outcomes of rehabilitation for people with CFS/ME.2014 · no comparison group · 76 in the study
    Summary

    This online survey, conducted by the charity Action for ME, examined free-text accounts of rehabilitation from 76 respondents who started therapy during or after 2008; the wider 2010 survey collected reports from 273 patients. Respondents described Graded Exercise Therapy (GET), Graded Activity Therapy (GAT) and Exercise on Prescription (EoP). Outcomes were rated with Clinical Global Impression scores. For GET, 3 (6) were very much better, 6 (12) much better, 5 (10) a little better, 7 (14) no change, 9 (18) a little worse, 10 (20) much worse and 9 (18) very much worse. For GAT, 8 (57) reported no change, 2 (14) much worse and 1 (7) very much worse; for EoP, 3 (23) a little worse, 3 (23) much worse and 1 (8) very much worse. Positive themes included supportive communication, routines and goals, and baselines with controlled pacing. Negative themes included poor communication, pressure to comply, conflict in beliefs, baselines experienced as unsustainable, worsening of symptoms and feeling blamed. Free-text comments described worsening symptoms, relapse, and stopping therapy, with pain or feeling worse reported.

  28. The search for pain relief in people with chronic fatigue syndrome: a descriptive study.2011 · no comparison group · 50 in the study
    Summary

    This descriptive, cross-sectional study asked people with chronic fatigue syndrome (CFS) who experienced pain which complementary/alternative medicine (CAM) and physiotherapy treatments they had tried for pain and how much benefit they perceived. 50 participants were recruited through CFS support groups across Scotland; interviews took place in their homes. 10 participants were severely affected. There was no comparison group; treatment duration and follow-up were not reported. At interview, 18 of 50 were currently receiving treatment for pain, and 3 were receiving physiotherapy. 45 participants reported previously trying 19 different CAM treatments. Acupuncture was the most frequently tried (23 participants); 14 reported benefit, and among 5 severely affected participants, 4 reported relief and 1 reported increased pain. Of 18 who tried massage, 5 reported reduced pain and 13 reported increased pain during treatment or worse the following day. Of 17 who tried reflexology, 9 reported increased pain and 4 found it beneficial. All who tried acupressure, lymphatic drainage, and hyperbaric oxygen reported improvements. 27 participants tried physiotherapy and reported 16 different interventions; spinal mobilisations, TENS, and ultrasound were reported to make no difference. 12 tried graded exercise therapy, and 11 stopped because it increased pain. For cognitive behaviour therapy, 11 reported benefit, 13 did not, and 22 refused. 41 of 50 were taking pain medication; 11 reported it eased pain, and Two were unable to take it due to side effects. Warm baths (29), heat applications (25), lying down/rest (22), and drinking water (17) were reported to ease pain.

  29. [Patients' experience with treatment of chronic fatigue syndrome].2009 · no comparison group · 828 in the study
  30. Graded Exercise Therapy for Chronic Fatigue Syndrome2001 · no comparison group · 59 in the study · 55 started · 55 with outcome data
    Summary

    This audit reported on all patients referred to the physiotherapy department at St Bartholomew’s Hospital, London (Bart’s) for graded exercise therapy between 1996 and 1999, to describe clinical and physiological outcomes of treatment for chronic fatigue syndrome. A total of 59 patients were referred and assessed, attending at least once. Supervised and graded exercise therapy was based on that given in the Bart’s trial; patients usually attended every fortnight rather than weekly. Other treatments given included antidepressants for depressive illness and either sleep hygiene and/or low dose tricyclic antidepressants for insomnia. The comparator was a previous research trial carried out in the same department. The primary outcome was the seven-point Clinical Global Impression (CGI) change score. Forty out of 55 patients (72 %) completed treatment and 15 (28%) dropped out; reasons for stopping treatment prematurely included feeling too unwell. Analysing by intention to treat, 26 patients out of 55 (47%) were rated by their therapist as having a positive outcome, and 17 patients out of 36 (47%) rated their outcome as positive. The median time spent on the exercise bicycle doubled from 4 (3-7) minutes before treatment to a median of 8 (6-12) minutes after treatment (p < 0.001), and fitness significantly increased with treatment (t = 4.13, 22 df, p < 0.001).

  31. Pacing and Exercise in Chronic Fatigue Syndrome2001 · no comparison group · 2,338 in the study
    Summary

    This paper reports a treatment audit carried out among the membership of three national support groups: The ME Association, Action for ME and the 25% Group. The largest questionnaire had 2,338 respondents. The audit collected self-reported outcomes of pharmacological, non-pharmacological and alternative approaches; no comparison group, randomisation, duration or follow-up was reported. For pacing, 1,949 respondents found it helpful, 201 reported no change, and 30 stated they were made worse. The same largest questionnaire asked about graded exercise: out of 1,214 who had tried it, 417 believed it had been helpful, 187 reported no change, and 610 respondents (around 50%) stated that graded exercise had made their condition worse. Withdrawals were not reported. The paper states that pacing takes into account fluctuations in symptom severity and accepts periods of rest and relaxation. It also reports concerns about graded exercise programmes, including inflexible programmes and relapse. The authors conclude: 'These results indicate that pacing is a highly acceptable and effective approach to activity management in CFS/ME.' Limitations of the audit are not reported.

  32. Clinically Meaningful Improvements in Long COVID Symptoms Following Ketogenic Metabolic Therapy Combined with Lifestyle Interventions-A Clinical Case Report and Review of the Literature.2025 · case report · 1 in the study
    Summary

    This case report describes one patient with Long COVID, POTS and ME/CFS at the OHSU Long COVID Clinic who enrolled in a community-based 12-week educational program. The program combined a ketogenic diet (low-carbohydrate and moderate-protein intake) with daily activities to entrain circadian rhythm, mindfulness-based strategies, and group health coaching; the patient also received thiamine 2000 mg/day and magnesium 3000 mg. No comparison group was reported. Clinical improvements were identified in five of the seven patient-reported measures across dysautonomia, shortness of breath, migraine disability, fatigue, and physical function. Within the first two weeks, chronic hypotension resolved and IV saline therapy was discontinued; she reported increased energy coinciding with ketosis. By the second month, sound and light sensitivity resolved, menstrual cycle normalized to 25 - 29 days, and headaches reduced from 4 - 5 times per week to once or twice a month. PEM after moderate exertion continued, while flushing episodes were diminished. Over 12 weeks, she lost 15% of body weight and BMI changed from 23 to 20 kg/m2; by month seven she worked cognitively 5 - 6 hours per day and exercised 20 minutes daily without triggering PEM, with BMI stabilizing at 21 kg/m. The patient did not report experiencing possible adverse reactions to KMT or vitamin supplementation. The authors state that whether observed benefits are attributed to the interventions or external factors such as placebo effect or natural disease progression cannot be determined, that the most impactful component is difficult to determine, and that results cannot be generalized.

  33. Orthostatic and Exercise Intolerance in Recreational and Competitive Athletes With Long COVID.2022 · case report · 3 in the study
    Summary

    This case series described 3 recreational and competitive athletes with post-acute sequelae of SARS-CoV-2 infection (PASC) and orthostatic or exercise intolerance; one also met criteria for POTS. Patient 1, a 31-year-old female recreational alpine skier, received compression stockings, an aggressive increase in fluid and sodium intake, and a structured graduated exercise regimen emphasizing recumbent exercises and strength training, with rowing as cardiovascular exercise, over 4 months. Her symptoms steadily improved, and at follow-up she felt ready to attempt skiing again. Patient 2, an 18-year-old male collegiate rower, was started on pyridostigmine and a rehabilitation program focused on supine exercise. Patient 3, a 38-year-old woman, followed a modified PASC exercise program on a rowing machine, from week 1 at 5 min/d 5 times/wk to week 12 at 27 min/d 5 times/wk. By week 28 of pregnancy her PASC symptoms were improved, although she had not completely recovered; by the end of pregnancy her PASC symptoms resolved. There was no comparison group, no randomisation and no blinding; harms were not reported. The authors caution that exercise recommendations should be given cautiously to patients with post-exertional malaise.

  34. Severe ME in Children.2020 · case report
    Summary

    The paper presents a series of case reports of individual cases to illustrate clinical presentation and general principles of management of severe paediatric ME/CFS. The author writes that there is very limited data on patients who are very severe, housebound or bedbound. No number of patients, clinic setting, comparison group or formal outcome measures are reported. Treatments described across the cases include nasogastric or nasojejunal tube feeding, intramuscular immunoglobulin monthly for 12 months, amitriptyline, carbamazepine, clarithromycin, doxycycline, opiates, a urinary catheter, active physiotherapy for three months and Tender Loving Care. The paper reports that one case made a very slow recovery, with tube feeding stopped after 3 years, and was operating at 95% of normal 20 years later; another made a full recovery by the end of two years; another recovered completely within 12 months after clarithromycin was changed to doxycycline and had no relapses at follow up 12 years later; and Case A made a full spontaneous recovery. Case B received active physiotherapy for three months, deteriorated further and remained severely affected 20 years later. Case C died. Harms include a traumatic hospital experience, a convulsive myoclonic jerk from noise and sensory overload. The author states that one should not draw too many conclusions from one case.

  35. Treatment of chronic fatigue and orthostatic intolerance with propranolol.2007 · case report · 1 in the study
    Summary

    This case report described one 13-year-old boy with chronic fatigue syndrome and orthostatic intolerance who was admitted in February 2001 after gradually worsening fatigue that began 3 years after a supposed viral infection. He was treated with propranolol 50 mg /H11003 3 and fludrocortisone 0.05 mg /H11003 1. Propranolol continued for 1 year; fludrocortisone was given only during the first month. A graded exercise therapy-program was also instituted, and cognitive behavioral therapy was offered, but he was not motivated for the latter. There was no comparison group. The report described his experience of overwhelming fatigue and other complaints gradually vanishing during the following months; after 1 week he walked without support, after 4 weeks he played soccer for the first time, and some weeks later he returned to school. A repeated head-up tilt-test was considered normal, with mean supine BP 79/52 mm Hg and HR 76 beats/minute, and mean values during 30 minutes of 60-degree upright tilt BP 95/65 mm Hg and HR 90 beats/minute. On discontinuation of propranolol there was no return of symptoms, and his cardiovascular responses to orthostatic stress remained adequate. Four years later he still avoided strenuous mental or physical exercise but was otherwise in good health with normal functional capacities. Harms were not reported. The authors stated that a placebo effect cannot be ruled out and that whether beta-receptor antagonists are generally beneficial in patients with CFS, with or without orthostatic intolerance, should be explored in randomized controlled trials.

  36. Does graded activity increase activity? A case study of chronic fatigue syndrome.2002 · case report · 1 in the study
    Summary

    This uncontrolled case study asked whether graded activity increases activity in a high-functioning patient with chronic fatigue syndrome (CFS). The participant was a 52-year-old married male with CFS who was working full-time. He received a 26-session graded activity intervention: daily 10-min walks, progressed to 40-min daily walks by session 14, plus a three times-a-week weight lifting regimen. There was no comparison group. Measures included a step counter, a daily diary of exercise activity and in vivo ratings, the CFS Symptom Inventory, SF-36, Beck Depression Inventory, and Beck Anxiety Inventory. From baseline to treatment termination, mean weekly step counts decreased 10.6%, while self-reported walk time increased from 0 to 155min a week. At 1-year follow-up, self-reported walk time had increased to 30min a day, 6 days a week, and step counts increased 21.2% from baseline to the 12-month follow-up. Weight lifting was suspended after a behavioral relapse, then resumed and increased to 18 repetitions of a 45lb bench press and 16 repetitions of a 20lb dumbbell press, three times a week. The CFS Symptom Inventory showed a 21.7% reduction at treatment termination; the SF-36 Physical Component summary score improved (52–64) from baseline to the 12-month follow-up; BAI and BDI scores decreased 36.4% and 31. 2%. Harms included a clinical relapse at session 20, a 4-week symptom flare-up, symptom flare-ups from exceeding weight lifting levels, and an 8-day illness with flu-like symptoms. The authors note limits: uncontrolled case study, unrecorded work hours, and the step counter did not fully capture non-walking activities.

  37. Effectiveness and safety of exercise therapy in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a meta-analysis.2025 · systematic review
    Summary

    This meta-analysis asked whether exercise therapy changes fatigue and harms in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The authors searched PubMed, Web of Science, Embase, and Cochrane to March 2024, with an update on June 7, 2025, and analyzed 13 studies with 1,305 patients: 659 in intervention groups and 646 in control groups. Interventions included aerobic training, guided graded exercise self-help, graded exercise therapy, gradual exercise, and Qigong forms. Control conditions included control, standard medical care, adaptive pacing therapy, CBT, and heart rate variability biofeedback. Outcomes were fatigue scale-14 (FS-14), multidimensional fatigue inventory (MFI-20), and adverse effects. The meta-analysis reported lower total, physical, and mental fatigue scores on FS-14 with exercise therapy than control; on MFI-20, physical fatigue and reduced activity improved, while general fatigue, mental fatigue, and reduced motivation did not differ significantly. Subgroup analysis reported conventional exercise was more favorable for total and physical fatigue, while Qigong was more favorable for mental fatigue. For harms, Clark et al. reported non-serious adverse events in ~1/4 of participants in both the intervention group and the control group, one case of serious adverse events in both groups, and no serious adverse reactions in either group; severe deterioration difference was not evident. Another study reported non-serious adverse events frequently, serious adverse events and severe adverse reactions relatively rare, and severe deterioration uncommon. The authors note publication bias and limitations.

  38. Effect of nonpharmacologic therapies on depressive symptoms in patients with chronic fatigue syndrome: a network meta-analysis.2025 · systematic review
    Summary

    This network meta-analysis examined nonpharmacologic therapies for depressive symptoms in patients with chronic fatigue syndrome (CFS). The authors searched PubMed, Cochrane Library, Web of Science, Embase, CNKI, Wanfang, CBM, VIP, and Sinomed for randomized controlled trials until March 26, 2025, and included 47 RCTs involving 4,028 participants. The review compared nonpharmacologic interventions with control conditions and measured depression or depressive symptoms with scales. Compared with control, the review reports significant differences for acupuncture (SMD = -1.91, 95% CI: -2.9 to -0.94), moxibustion (SMD = -2.91, 95% CI: -4.61 to -1.22), Tuina (SMD = -2, 95% CI: -3.64 to -0.38), diet therapy (SMD = -5.64, 95% CI: -8.98 to -2.29), electrical stimulation (SMD = 1.9, 95% CI: 0.03 to 3.78), Ap + Mox (SMD = 2.53, 95% CI: 1.17 to 3.91), and Ap + Mox + Ae (SMD = 3.16, 95% CI: 0.39 to 5.98). The review states that relaxation therapy, AER, RT, and Qigong did not markedly improve depressive symptoms, and psychotherapy did not show significant effects. Harms were not reported as counts; the review includes a statement that graded exercise therapy may exacerbate symptoms in certain CFS patients, a statement about exercise therapy, the patient’s energy limit, characteristic post-exertional malaise (PEM), and efficacy, and a statement that Tuina has no adverse reactions. The authors state heterogeneity, inconsistent depression scales, and medium risk of bias in most included studies, with some interventions from few small studies, so results should be viewed with caution.

  39. Comparative efficacy of various exercise therapies for chronic fatigue syndrome: A systematic review and network meta-analysis.2025 · systematic review
    Summary

    This systematic review and network meta-analysis asked whether exercise therapies help chronic fatigue syndrome (CFS). The review included 25 randomized controlled trials; 20 trials (n = 2,831) were eligible for network meta-analysis, and 3,602 patients with CFS were included overall. Exercise modalities were GET, Qigong, Yoga, strength/resistance training, and running, compared with waitlist, specialist medical care, or relaxation/flexibility. Outcomes were fatigue, depression, anxiety, physical function, and sleep quality. For fatigue at the end of treatment, GET compared with waitlist had MD −6.93 (95% CI −10.85 to −3.01; moderate certainty); Qigong MD −5.02 (95% CI −9.79 to −0.25; low certainty); running MD −9.66 (95% CI −18.20 to −1.12; very low certainty); strength/resistance training MD −5.79 (95% CI −14.17 to 2.58; very low certainty); Yoga MD −3.89 (95% CI −12.89 to 5.11; very low certainty). For depression, GET MD −5.27 (95% CI −7.38 to −3.16; low certainty). For anxiety, GET MD −2.88 (95% CI −5.10 to −0.66; low certainty). For physical function, GET MD 6.41 (95% CI 4.87 to 7.96; moderate certainty), and Qigong MD 2.30 (95% CI −0.77 to 5.37; low certainty). For sleep, GET MD −2.32 (95% CI −4.35 to −0.29) and Qigong MD −1.30 (95% CI −2.44 to −0.16), both low certainty. The authors state that physical function and sleep improvements remained below clinically meaningful thresholds. The text mentions symptom exacerbation in 'some patients' but gives no count for this review.

  40. Effectiveness of Exercise-Based Rehabilitation in Chronic Fatigue Syndrome: A Systematic Review and Meta-analysis.2025 · systematic review
    Summary

    This systematic review and meta-analysis asked whether exercise-based rehabilitation improves fatigue and functional capacity in adults with CFS compared with conventional treatment. Setting was not reported. 11 studies were included in the qualitative review, and 7 randomized controlled trials (n = 2,276 participants) were included in the meta-analysis. The programs included aerobic training, resistance exercises, GET, Qigong, and multimodal interventions; outcomes were grouped as short-term (< 3 months), medium-term (3 to 6 months), and long-term (≥ 6 months). For short-term fatigue, the review reported n = 720, SMD = −0.49, 95% CI [−0.75, −0.24], p = 0.0001. Short-term functionality was n = 685, SMD = 0.09, 95% CI [−0.05, 0.249], p = 0.20, with the effect slightly favoring control and not reaching significance. Medium-term fatigue was n = 501, SMD = −0.53, 95% CI [−0.947, −0.119], p = 0.01. Medium-term functionality was n = 366, SMD = 0.31, 95% CI [0.105, 0.517], p = 0.003, and the text states exercise therapy did not show improvement compared with conventional treatments. Long-term fatigue was n = 531, SMD = −0.07, 95% CI [−0.517, 0.365], p = 0.74; long-term functionality was n = 421, SMD = 0.03, 95% CI [−0.473, 0.536], p = 0.90. Adverse-event reporting was inconsistent. Worsening and stopping were not reported. Authors state low to moderate certainty and weak recommendation.

  41. Evaluating pacing therapy (PT) versus graded exercise therapy (GET) for improving fatigue, pain, and quality of life in adults with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review.2025 · systematic review
    Summary

    This systematic review examined pacing therapy (PT) and graded exercise therapy (GET) or graded exercise self-help (GES) for adults with ME/CFS, with adaptive pacing therapy (APT) and specialist medical care (SMC) as comparators. It included six studies; recorded samples were 640, 197, 957, 481 and 640, and searches were limited to English, with all studies being UK-based. Outcomes were fatigue, pain, quality of life/physical function and adverse events. Drop-outs (n = 486) meant the final analysis included 77% of the initial sample. Bourke et al. reported less frequent muscle pain with GET versus APT (p = 0.01, difference = 0.17) and SMC (p = 0.01, difference = 0.38), and greater joint-pain reductions versus APT (p = 0.02, difference = 0.15) and SMC (p = 0.07, difference = 0.22). Clark et al. reported GES scored 4.2 points lower on CFQ (p < 0.0001) and 6.3 points higher on SF-36PF (p = 0.006) than SMC; 64% versus 44% improved in fatigue and 45% versus 22% in physical functioning. White et al. reported recovery on CFQ of 33% with GET, 22% with APT, 21% with SMC; SF-36PF recovery was 53%, 35%, and 41%. Sharpe et al. found APT and SMC improved fatigue and physical functioning (p < 0.0001), not GET, with no significant between-group differences. Geraghty et al. reported 32% worsening, 49% no change, 19% improvement; PT 44% versus GET 12% improvement, and GET 74% versus pacing 14% worse. Dougall et al. reported physical functioning decline in pacing 25%, SMC 18%, and GET 11% (p = 0.0007), and pooled NSAEs were 74%.

  42. Chinese herbal medicine for the treatment of chronic fatigue syndrome: A systematic review and meta-analysis.2022 · systematic review
    Summary

    This systematic review and meta-analysis asked whether Chinese herbal medicine (CHM) treats chronic fatigue syndrome. It included 84 RCTs with 6,944 participants; all studies were conducted in China. Participants received CHM formulas, alone or with Western conventional medicine, graded exercise therapy, or health guidance, and were compared with contrast groups that included Western conventional medicine, graded exercise therapy, health guidance, or placebo, for varying durations. The review measured FS-14, FAI, SCL-90, SAS, SDS, clinical symptom scores, IGA, IGG, IGM, NK cell levels, a clinical rate outcome, and adverse events. CHM decreased FS-14 scores (WMD: –1.77; 95%CI: –1.96 to –1.57; p < 0.001) and FAI scores (WMD: –15.75; 95%CI: –26.89 to –4.61; p < 0.01). It also decreased SCL-90, SAS, SDS, and clinical symptom scores and elevated IGA, IGG, and IGM. NK cell levels showed no significant difference between groups (WMD: 2.30; 95%CI: –0.47 to 5.07; p = 0.104); one study comparing CHM with placebo reported higher NK cell levels (WMD: 4.92; 95%CI: 2.27–7.57; p < 0.001). The clinical rate outcome was higher in the treatment group (RR = 1.41; 95%CI: 1.33–1.49; p < 0.001). Adverse events in the CHM group included mild nausea, dry mouth, indigestion, constipation, and fever; serious adverse events or deaths were not found, and two studies reported no adverse events. Worsening and stopping treatment were not reported. The authors state the reports were of poor quality and results should be interpreted cautiously, with methodological flaws, clinical heterogeneity, and all trials in China limiting the findings.

  43. A systematic literature review of randomized controlled trials evaluating prognosis following treatment for adults with chronic fatigue syndrome.2022 · systematic review
    Summary

    This systematic review asked how adults with chronic fatigue syndrome fare after CBT or GET. It included 15 publications comprising 1990 participants from the UK, the Netherlands, the USA, and New Zealand. Treatments were compared with control conditions such as relaxation, medical care, and wait-list. Outcomes included fatigue, physical functioning, global improvement, and global worsening at post-treatment and follow-up. Treatment duration varied across trials and is not summarised here. Pooled analyses reported more improvement with CBT than control: 23% (95% CI 16–31) more participants improved in fatigue, 14% (95% CI 4–23) more in physical functioning, and 20% (95% CI 11–29) more rated themselves as improved; 8% (95% CI 1–14) fewer reported global worsening. For GET, 23% (95% CI 15–31) more improved in physical functioning and 26% (95% CI 19–32) more reported global improvement; 10% (95% CI 4–16) fewer reported global worsening. Individual studies reported worsening: 21% seriously deteriorated with self-help GET in Clark et al., 9% with CBT and 6% with GET in White et al., and 7% deteriorated and attributed this to treatment with CBT in Sharpe et al. Whether worsening was followed by stopping treatment is not reported. The authors state limitations include clinical heterogeneity, reliance on self-report, and possible limited generalisability to severe CFS.

  44. What treatments work for anxiety and depression in children and adolescents with chronic fatigue syndrome? An updated systematic review.2022 · systematic review
    Summary

    This systematic review updated searches from 2015 to 2020 in Cochrane Library, Medline, Embase and PsycINFO for studies of children and adolescents with CFS/ME and validated measures of depression and/or anxiety. Combined with previous reviews, 16 studies and 965 participants were included; follow-up ranged from immediately post-treatment to 21 years. Treatments included CBT, the Lightning Process, valacyclovir, pacing, gammaglobulin, placebo, and inpatient or specialist care programmes. An RCT compared Lightning Process plus specialist medical care with specialist medical care alone; the review reports adjusted mean differences in depression and anxiety scores at 6 and 12 months, for example depression −1.5 (−3.5 to 0.5, 0.1) at 6 months and −1.8 (−3.4 to −0.1, 0.04) at 12 months. An observational cohort of routine specialist care measured depression and anxiety at baseline but not post-treatment. CBT-type interventions had most evidence for improving comorbid anxiety and/or depressive symptoms, but delivery and modality varied. A trial reported a deterioration in school attendance in the pacing arm. The review reports insufficient evidence to draw conclusions, and no study specifically targeted depression or anxiety. The authors state the evidence is poor and insufficient for meta-analysis.

  45. A mixed-methods systematic review of post-viral fatigue interventions: Are there lessons for long Covid?2021 · systematic review
    Summary

    This mixed-methods systematic review asked whether post-viral fatigue interventions offer lessons for long Covid. Online databases were searched in October 2020, and 40 papers were selected. The included fatigue interventions involved 25 studies in CFS/ME, nine in fibromyalgia and eight in unexplained fatigue. Treatments varied widely and were compared with controls, typically usual care or waiting lists; fatigue severity was the main outcome. Intervention duration varied and is not quantified in the recorded data. The review reported mean differences for several interventions. The largest mean difference was for the Three Principles/Innate Health programme (MD -39.0, 95% CI -51.8 to -26.2, SMD = 1.670). Group-based CBT also showed reductions (MD -27.5, 95% CI -33.7 to -21.3, SMD = 1.170; MD -23.7, 95% CI -29.2 to -18.2, SMD = 2.266). Smaller mean differences were reported for GET (MD -11.5, 95% CI -17.6 to -5.4, SMD = 0.524) and self-regulation based physical activity (MD -9.9, 95% CI -16.3 to -3.4, SMD = 0.513). TENS (MD -6.0, 95% CI -16.9 to 4.9, SMD = 0.239), Tai Ji Quan (MD -0.4, 95% CI -9.6 to 8.9, SMD = 0.023) and supportive listening (MD 1.06, 95% CI -1.4 to 3.6, SMD = -0.111) showed little or no benefit. Doxycycline mean differences were positive (MD 6.3, 95% CI 3.7 to 8.8, SMD = -0.752; MD 8.75, 95% CI 6.36 to 11.14, SMD = -1.120). No side effects, withdrawals or worsening were reported in the recorded data.

  46. Cognitive and emotional variables predicting treatment outcome of cognitive behavior therapies for patients with medically unexplained symptoms: A meta-analysis.2021 · systematic review
    Summary

    This systematic review and meta-analysis asked whether pre-treatment cognitive and emotional variables predict CBT outcome in adults with medically unexplained symptoms, including chronic fatigue syndrome, fibromyalgia syndrome, irritable bowel syndrome, and somatoform disorders. It searched databases and references for articles published in English or German until August 2020 and included 37 eligible studies, of which 23 provided data for meta-analyses. CBT was the psychological treatment examined; treatment duration and any comparator group were not reported. The review measured associations between baseline patient characteristics and symptom intensity, physical functioning, or emotional and social functioning after CBT. A comorbid mood disorder predicted increased symptom intensity at the end of therapy (r = 0.32, 95%-CI: 0.19, 0.44), and a comorbid anxiety disorder was associated with higher symptom intensity (r = 0.18, 95%-CI: 0.12, 0.24). Symptom catastrophizing and worries predicted increased symptom intensity (r = 0.34, 95%-CI: 0.20, 0.46). Somatosensory amplification predicted low emotional and social functioning (r = 0.46, 95%-CI: 0.03, 0.75). Symptom acceptance and self-efficacy correlated with less symptom intensity (r = 0.25, 95%-CI: 0.35, 0.14). Negative affectivity did not predict the reported outcomes. Side-effect and withdrawal counts were not reported.

  47. Adverse outcomes in trials of graded exercise therapy for adult patients with chronic fatigue syndrome.2021 · systematic review
    Summary

    This secondary meta-analysis examined adverse outcomes in ten published trials of graded exercise therapy (GET) for adult patients with chronic fatigue syndrome; the trials involved 1279 participants. GET was compared with control interventions. The authors examined CGI change scores of 6 or 7 (“much worse” or “very much worse”), withdrawals from treatment, and drop-outs from trial follow up, using outcomes at the end of treatment when available. CGI scores of 6 or 7 were reported by 14/333 (4%) after GET and 26/334 (8%) after control interventions (RR 0.62, 0.32 to 1.17). Withdrawals from treatment occurred in 64/535 (12%) after GET and 53/534 (10%) after control interventions (RR 1.21, 0.86 to 1.69). Drop-outs from trial follow up occurred in 74/679 (11%) after GET and 41/600 (7%) after control interventions (RR 1.51, 1.03 to 2.22). The paper reported no significant differences between groups for CGI score or withdrawal from treatment, but a significantly larger number dropping out of trial follow up after GET. Powell et al. reported CGI scores of 3–7 in 15/95 (16%) after GET compared to 28/32 (88%) after control; Jason reported 60% after GET versus 53% after control (no data given). The paper also reported that SAEs were more common in GET participants in one trial in comparison to specialist medical care participants, but independent scrutineers did not attribute these SAEs to GET. The GRADE certainty was low; the authors reported imprecision, incomplete data and non-blinding.

  48. Cost-effectiveness of Interventions for Chronic Fatigue Syndrome or Myalgic Encephalomyelitis: A Systematic Review of Economic Evaluations.2021 · systematic review
    Summary

    This systematic review examined the cost-effectiveness of interventions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). It included 10 economic evaluations based on randomised controlled trials; searches covered MEDLINE (1946–2020) and EMBASE (1974–2020). The included evaluations examined CBT, GET, counselling, specialist medical care, adaptive pacing, guided support groups, fatigue self-management, treatment as usual, pragmatic rehabilitation, supportive listening and the lightning process, alone or with other care. Study sizes ranged from 100 to 640 participants. Outcomes were costs and health effects such as QALYs or fatigue scores. In the largest trial, CBT had a 59.5% likelihood of being cost-effective versus GET (34.8%), specialist medical care (5.5%) and adaptive pacing (0.2%) at £30,000 per QALY. One trial reported CBT was dominated by counselling for cost per improved fatigue score. GET versus CBT had an incremental cost of £193 and incremental effect of 0.71. GET was more cost-effective than usual care plus self-help booklet above £987 for a clinically significant fatigue improvement. For the lightning process plus specialist medical care, incremental cost was £390 and incremental effect 0.095 QALYs, with £1508 incremental net monetary benefit. Side effects and withdrawals were not reported.

  49. The effect of physiotherapy on fatigue and physical functioning in chronic fatigue syndrome patients: A systematic review.2018 · systematic review
    Summary

    This systematic review asked whether physical therapy treatments for chronic fatigue syndrome have support from randomized controlled trials. The authors searched MEDLINE, Cochrane Library, and PEDro, and required randomized controlled trial design, English publication, and a publication window stated in the abstract. Four studies were included, and the studies were evaluated with the Jadad score. The abstract does not name the participants' location, the number of people enrolled or analysed, the treatment dose or duration, or the comparator used in the included trials. It reports no numerical results of the included studies, no side effects, and no withdrawals. The review suggests that a treatment that is more effective than all the others cannot be defined. The authors write: “This conclusion is related to the low number of investigated studies; therefore, the collected results cannot be generalized.” In the conclusion, the authors state that rehabilitation programs that promote physiotherapy techniques such as exercise, mobilization, and body awareness (e.g., MRT and GET) are the most effective in reducing medium and long-term fatigue severity in CFS patients. They also state that chronic fatigue syndrome is not yet a well-understood pathology and that physical mechanisms influencing outcomes still need more study.

  50. Cost-effectiveness of interventions for medically unexplained symptoms: A systematic review.2018 · systematic review
    Summary

    This systematic review asked whether interventions for medically unexplained symptoms (MUS) or functional somatic syndromes (FSS), including fibromyalgia, irritable bowel syndrome and chronic fatigue syndrome, are cost-effective. The search covered PubMed, PsycINFO, NHS-EED and the CEA registry to 15 June 2018 and included 39 full economic evaluations in adult patients. Interventions varied: group CBT, individual CBT, graded exercise therapy, adaptive pacing therapy, multidisciplinary rehabilitation, counselling, educational and pharmacological treatments. Comparators included usual care, waiting lists, other physical or psychological treatment and other drugs. Outcomes were incremental costs, incremental effects and ICERs, using QALYs or clinical scales. Results differed by study: in CFS, CBT and GET dominated specialist medical care on average, with ICERs of €24,475 and €31,456 per QALY; APT had an ICER of €73,576 per QALY and SMC was preferred over APT for all outcomes. MRT appeared not cost-effective compared with CBT. In fatigue, graded exercise had an ICER of €1,377 per unit of clinically significant improvement on the Chalder Fatigue Scale, and counselling was dominated by usual care plus a self-help booklet. No side-effect or withdrawal counts were recorded. The authors state language restrictions and limited comparability; they describe heterogeneity across the included studies.

  51. Do evidence based interventions for chronic fatigue syndrome improve sleep? A systematic review and narrative synthesis.2017 · systematic review
    Summary

    The review was a systematic review and narrative synthesis of eight studies, with searches completed in March 2015. Included studies enrolled adults aged 18 or over meeting Oxford and/or CDC criteria for chronic fatigue syndrome (CFS) and evaluated CBT, GET, or combined approaches with a sleep outcome. Studies evaluated 12 weeks of individual graded exercise sessions (29), a 12-week group cognitive behavioural stress management programme (44), a 2-participant case study, pragmatic rehabilitation with 2 sessions (37), 2 sessions plus telephone contact (39), or 7 sessions (38) versus standardised medical care (34), 10 sessions of multi-convergent therapy (12), 10 nurse-led pragmatic rehabilitation sessions (95), and 24 weeks of individual CBT (161) or GET (160). One GET study found no significant difference in PSQI ratings; another reported significant improvements in sleep difficulties for CBT and GET compared with APT and specialist medical care. A CBSM pilot found reduced frequency, but not severity, of unrefreshing sleep. Powell et al. (2001) reported significant PR improvements at 3, 6 and 12 months; Wearden et al. (2010) reported improvement at 20 weeks but not at 70 weeks. The case study reported ratings decreased from 18 & 19/20 to 0. Thomas et al. reported a significantly greater number of participants with improved sleep in the MCT group. No harms events were recorded. The authors state that the small number of studies and differences in design, sample inclusion criteria and outcomes meant strong conclusions could not be made.

  52. Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop.2015 · systematic review
    Summary

    This systematic review examined treatments for adults with ME/CFS. It included 35 treatment trials in 45 publications; trials enrolled predominantly middle-aged women from ME/CFS specialty clinics and used CFS case definitions. Treatments were compared with placebo, usual care, wait-list, relaxation, adaptive pacing, CBT, or other therapies. In 2 fair-quality trials (n=324), rintatolimod improved cardiopulmonary exercise test tolerance (36.5% versus 15.2%; P=0.047), exercise duration (10.3% versus 2.1%; P=0.007), and exercise work (11.8% versus 5.8%; P=0.01). In a small trial of 30 participants, valganciclovir improved fatigue on 1 scale but showed no statistically significant differences for other measures. Trials of galantamine, hydrocortisone, IgG, isoprinosine, and fluoxetine indicated no beneficial effects but were limited by small numbers. Counseling and behavior therapies improved fatigue, function, quality of life, work impairment, and global improvement in some trials (low to moderate strength of evidence). A meta-analysis of 4 CBT trials found no statistically significant difference in SF-36 physical function (weighted mean difference, 10.42 [95% Cl, -3.86 to 24.69]); a sensitivity analysis found 6.02 [Cl, 1.05 to 10.88]. GET improved function (10.68 [Cl, 6.32 to 16.88]), fatigue (4 trials, n=619), and global improvement (relative risk, 1.58 [Cl, 1.24 to 2.47]). In the PACE trial, deterioration of physical function was 25% with adaptive pacing, 18% with usual care, and 11% with GET (P<0.001). Harms included galantamine: 90% reported harms and 2% serious events, none attributed to study drug; IgG headaches 93% versus 60%; GET serious adverse events 17 versus 7. GET withdrawals were 37% versus 22%, and 20% declined repeat exercise testing. Adverse effects were rarely reported overall.

  53. Differential effects of behavioral interventions with a graded physical activity component in patients suffering from Chronic Fatigue (Syndrome): An updated systematic review and meta-analysis.2015 · systematic review
    Summary

    This updated systematic review and meta-analysis asked whether behavioral and psychological interventions with a graded physical activity component affect fatigue severity, physical functioning, physical activity and psychological distress in adults with idiopathic chronic fatigue or CFS/ME, and whether trial characteristics moderate effects. Sixteen randomized controlled trials (N = 2004) were included; most were from the United Kingdom (n = 9) and the Netherlands (n = 3), in secondary–tertiary care (n = 11) or primary care (n =3). Interventions included GET, CBT with graded exercise, pragmatic rehabilitation and multicomponent approaches, compared with passive or active controls. Assessment was at post-treatment (M = 5.2 months) and follow-up (M = 11.7 months). Significant medium effects were found for fatigue severity at post-treatment (g = 0.61) and follow-up (g = 0.66). Physical functioning effects were g = 0.29 and g = 0.38. Physical activity was not significant at post-treatment (g = 0.11) but was at follow-up (g = 0.28); physical capacity was g = 0.27. Depression effects were g = 0.41 and g = 0.37; anxiety g = 0.28 and g = 0.25. Minimal contact interventions had additional beneficial effects upon fatigue (g = 0.96) and depression (g = 0.85). No significant difference was found between interventions with and without a psychological component. Some trials showed negative effects (g = −0.20, g = −0.10, g = −0.97). Drop-out in intervention conditions ranged from 0% to 35%; side effects were not reported.

  54. Diagnosis and Treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2014 · systematic review
    Summary

    This systematic review summarizes research on methods of diagnosing myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and the benefits and harms of multiple medical and nonmedical treatments. It included 71 studies in 81 publications: 36 observational studies on diagnosis and 35 trials of treatments. Searches covered MEDLINE, PsycINFO, and the Cochrane Library. The treatment trials compared rintatolimod with placebo, and counseling therapies or graded exercise treatment (GET) with no treatment, relaxation, or support. Treatment duration was not reported. Outcomes included exercise performance, fatigue, function, quality of life, employment outcomes, and adverse events. The review reports that rintatolimod compared with placebo improved measures of exercise performance, and that counseling therapies and GET compared with no treatment, relaxation, or support improved fatigue, function, and quality of life; counseling therapies also improved employment outcomes. GET was associated with higher numbers of reported adverse events compared with counseling therapies or controls. Harms were generally inadequately reported across trials. The authors conclude that rintatolimod improves exercise performance in some patients (low strength of evidence), while counseling therapies and GET have broader benefit but have not been adequately tested in more disabled populations (low to moderate strength of evidence), and that other treatments and harms have been inadequately studied (insufficient evidence). They state that diagnostic methods were studied only in highly selected patient populations, and that treatment trials were limited in number and had small sample sizes and methodological shortcomings.

  55. Interventions in pediatric chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review.2013 · systematic review
    Summary

    This systematic review searched CINAHL, PsycINFO and Medline to May 2012, with a limited update in October 2012, for studies of interventions in children and adolescents with CFS/ME. It included 24 articles based on 21 studies, with variable designs and quality. In Wright (2005), 13 participants were randomized to a structured tailored incremental rehabilitation program or pacing; the review reports improvements in activity and school attendance with the program immediately after treatment compared with pacing. Viner (2004) reported 43% of the treatment group had complete resolution of CFS/ME compared with 4.5% with supportive care. Lim (2002) reported that before an inpatient program 94% attended school less than half-time, and 78% attended full-time or with occasional absences only at follow-up. Szyndler (2003) reported problem improvement or resolution in 31% by clinician rating and 86% by family rating. Van Geelen (2010) reported 52% nearly complete improvement and 48% no improvement. For harms, Rowe (1997) reported adverse effects common, and Nijhof (2012) reported no serious adverse events. The authors state that methodological inadequacies and inconsistent approaches limit interpretation.

  56. How to exercise people with chronic fatigue syndrome: evidence-based practice guidelines.2012 · systematic review
    Summary

    This systematic literature review asked which exercise modalities should be used for people with chronic fatigue syndrome (CFS). It included 12 studies of adults and/or children diagnosed with CFS by official criteria, and examined graded exercise therapy (GET) and cognitive behavioural therapy (CBT) interventions. Treatments were compared with control interventions such as flexibility or relaxation therapy, with adaptive pacing therapy (APT), or with different doses of GET. Outcomes were fatigue and physical functioning. The review reports that the included studies confirm a positive effect (P <0Æ05) of CBT and GET on fatigue and physical functioning. In the PACE study, CBT and GET were associated with significantly less fatigue (CBT, P =0Æ0027; GET, P <0Æ0059) and improved physical function (CBT, P =0Æ0002; GET, P <0Æ0001) compared with APT. A comparison of three GET intervention groups found no significant difference in fatigue or physical functioning, but a similar improvement (P <0Æ001) in all three groups compared with the control group. Flexibility or relaxation therapy alone did not significantly improve (P >0Æ05) fatigue or physical functioning. The authors conclude that exercise therapy should be aerobic and comprise 10–11 sessions over 4–5 months, with home exercises five times a week starting at 5–15 min and increasing to 30 min. Side effects and withdrawals were not reported. The authors state the findings should be interpreted with some caution.

  57. Cognitive behavioral therapy and graded exercise for chronic fatigue syndrome: A meta‐analysis.2011 · systematic review
    Summary

    This meta-analysis asked whether cognitive behavioral therapy (CBT) and graded exercise therapy (GET) show positive effect sizes in chronic fatigue syndrome (CFS), also known as myalgic encephalomyelitis (ME). Twenty studies were included: five GET trials (N = 170) and 16 CBT trials (N = 1,457); one trial contributed an effect size to both groups, leading to a total of 21 effect sizes. Trials were identified through database and reference searching in April 2011. CBT and GET were compared with control conditions and with each other. CBT treatment contact across trials ranged from 6 to 16 hours. Outcomes were post-treatment fatigue, anxiety, depression and functional impairment. The pooled overall effect size was g = 0.26 (CI = 0.08, 0.43) for GET and g = 0.33 (CI = 0.23, 0.43) for CBT. Fatigue effect sizes were g = 0.41 for GET and g = 0.36 for CBT; functional impairment g = 0.39 for GET and g = 0.36 for CBT; depression g = 0.15 for GET and g = 0.32 for CBT; anxiety g = 0.01 for GET and g = 0.15 for CBT. There were no significant differences between the two treatment types on overall outcome or the four outcome categories. Across studies, a median of 12% of GET participants (range = 10–18) and 17% of CBT participants (range = 0–46) dropped out of treatment or did not complete post-treatment assessment measures. Worsening and side effects were not reported.

  58. Chronic fatigue syndrome.2011 · systematic review
    Summary

    This systematic review asked what the effects of treatments for chronic fatigue syndrome are. The authors searched Medline, Embase, The Cochrane Library and other databases up to March 2010, included 46 systematic reviews, RCTs or observational studies, and rated the quality of the evidence with GRADE. They list the treatments covered: antidepressants, cognitive behavioural therapy, corticosteroids, dietary supplements, evening primrose oil, galantamine, graded exercise therapy, homeopathy, immunotherapy, intramuscular magnesium, oral nicotinamide adenine dinucleotide and prolonged rest. The abstract gives no finding for any of them and names no included study, so no results are listed here.

  59. [Exercise therapy for patients with chronic fatigue syndrome].2011 · systematic review
    Summary

    This systematic review asked whether exercise treatment helps patients with chronic fatigue syndrome. The authors updated the search to 30.9. 2009 and included seven effect studies in a meta-analysis; the review does not state a total participant number or setting. Treatments included graded exercise therapy, exercise therapy, qigong (15 weeks) and anaerobic activity therapy (26 weeks), given for 12 weeks, 15 weeks, 26 weeks or 12 months; comparisons included no exercise, relaxation/stretching, standard care or waiting list. Outcomes were fatigue, pain and health-related quality of life. For fatigue, the review reports a pooled difference of 5,09 points (95 % KI: –8,79 til –1,40) in four studies using the Chalder Fatigue Scale after 12 weeks, plus single-study differences of –5,40 (95 % KI: –7,03 til –3,77), –0,33 (95 % KI: –0,94 til 0,28) and 0,15 (95 % KI: –0,54 til 0,84). For pain, two studies found no difference: –0,97 (95 % KI: – 2,44 til 0,50) and –0,51 (95 % KI: –2,22 til 1,20). For health-related quality of life, results were uncertain: –7,06 (95 % KI: –14,60 til 0,47) and -9 (95 % KI: –19 til 1). No included study reported side effects; dropout in exercise groups varied from 6 % to 32 % (median 12 %). The authors rate the evidence as moderate to low and note variation in design and results.

  60. Interventions for the treatment, management and rehabilitation of patients with chronic fatigue syndrome/myalgic encephalomyelitis: an updated systematic review.2006 · systematic review
    Summary

    This updated systematic review asked whether any intervention is effective for treatment, management or rehabilitation of adults and children with CFS/ME. The authors searched eleven electronic databases and included 70 studies, of which 59 were RCTs; comparisons were between treatment and control groups. Interventions included CBT, GET, rehabilitation, immunological and pharmacological treatments, supplements and complementary therapies. Outcomes covered physical, psychological, laboratory/physiological and quality-of-life measures. CBT and GET appeared to reduce symptoms and improve function based on RCTs. In a CBT trial (n=69), physical functioning, fatigue and symptoms favoured CBT (P<0.003) and school attendance favoured treatment (P=0.04). Another CBT trial (n=65) found no significant difference for fatigue, anxiety and depression, or disability. In GET trials, CGI and fatigue favoured treatment (n=49; P<0.03), and fatigue and depression/anxiety were significantly better (n=61; P=0.027). One GET trial reported withdrawal of one patient in each group because of worsening symptoms; eleven patients withdrew because of adverse events in a GET with or without fluoxetine trial. Galantamine (n=434) showed no significant differences; 130 patients withdrew, 389 reported adverse events and 88 withdrew. Acetyl-L-carnitine and propionyl-L-carnitine (n=90) improved general fatigue in PLC (P=0.004) and combined group (P<0.001), and mental fatigue in ALC group (P=0.015); 8 patients withdrew due to side effects. Staphylococcus toxoid (n=98) had 13 treatment-group and 7 placebo-group patients with side effects. Hydrocortisone/fludrocortisone (n=80) found no significant differences.

  61. Systematic review of mental health interventions for patients with common somatic symptoms: can research evidence from secondary care be extrapolated to primary care?2002 · systematic review
    Summary

    This systematic review examined the strength of evidence for mental health interventions in three common somatic conditions: chronic fatigue syndrome, irritable bowel syndrome, and chronic back pain. It also asked whether evidence from secondary care can be extrapolated to primary care. The search covered papers published between 1966 and September 2001. Sixty one studies were identified; 20 were classified as primary care and 41 as secondary care. The review reported that cognitive behaviour therapy and behaviour therapy were effective in both primary and secondary care in patients with back pain, although the evidence was more consistent and the effect size larger for secondary care. It reported that antidepressants seemed effective in irritable bowel syndrome in both settings but ineffective in chronic fatigue syndrome. Cognitive behaviour therapy was reported as effective in chronic fatigue syndrome in secondary care, although brief cognitive behaviour therapy was ineffective; in primary care patients, there was no difference in effectiveness between brief therapy and counselling. Some evidence of effectiveness of graded exercise in secondary care patients was reported. The authors noted methodological weaknesses: for most treatments they could draw only qualified conclusions. Side-effect and withdrawal data were not recorded. The authors concluded that treatment seems to be more effective in patients in secondary care than in primary care.

  62. Interventions for the treatment and management of chronic fatigue syndrome: a systematic review.2001 · systematic review
    Summary

    This systematic review asked whether interventions for chronic fatigue syndrome (CFS) work. Nineteen specialist databases were searched, and 44 trials met inclusion criteria: 36 randomized controlled trials and 8 controlled trials. Treatments were grouped by type and compared with control conditions. Outcomes were classified as positive, negative, or no effect. Three randomized controlled trials of GET all showed an overall beneficial effect compared with control groups. Three of four randomized controlled trials of CBT found a positive overall effect; one controlled trial did not find overall beneficial effects. One randomized controlled trial found no effect of fluoxetine either alone or with GET. Hydrocortisone showed an overall beneficial effect in one randomized controlled trial and some beneficial effects in another. For immunoglobulin, two randomized controlled trials showed an overall beneficial effect, two showed some positive effects, and the largest reported no effect. Acyclovir showed a negative effect for one outcome. Randomized controlled trials of fludrocortisone, antidepressants, moclobemide, sulbutiamine, growth hormone and galanthamine hydrobromide found no effects. Oral NADH showed an overall beneficial effect in one randomized controlled trial. Harms included withdrawals from immunoglobulin therapy (2 due to severe constitutional symptoms, 1 due to a skin eruption, 1 due to mild but transient liver failure, 1 due to phlebitis, and 2 whose adverse effects were not reported), 3 withdrawals from acyclovir due to reversible renal failure, and 2 participants leaving the magnesium group after a generalized rash. CBT trials had a dropout rate of 19% (114/589), GET trials 18% (68/370), and pharmacological trials 11% (99/869).

  63. EFFECTIVENESS OF THERAPEUTIC INTERVENTIONS FOR CHRONIC FATIGUE SYNDROME: A NARRATIVE REVIEW2026 · review
    Summary

    This narrative review summarized treatment studies in chronic fatigue syndrome (CFS), also called myalgic encephalomyelitis (ME). A structured search of PubMed and Google Scholar, with ResearchGate used only to retrieve full texts, was performed in June 2026 and covered publications from 2001 to 2025; of 132 identified publications, 54 were included. Treatments included CBT, exercise-based interventions, nutritional supplements (CoQ10, NADH, selenium, creatine, combination nutraceutical therapy), rituximab and rintatolimod. Five nutritional studies assessing 265 patients reported significant fatigue improvement (p < 0.001 to p = 0.038); three studies involving 192 patients reported significant sleep improvement (p = 0.008–0.018), while one study of 27 patients receiving CoQ10 + selenium found no effect on sleep (p = 0.480). Two CoQ10 studies involving 171 patients reported significant quality-of-life improvement (p = 0.001–0.048), whereas two studies involving 46 patients found no improvement (p > 0.05). In the RituxME phase III trial, clinical response was 26.0% (20/77) with rituximab vs 35.1% (26/74) with placebo (p = 0.22); adverse events occurred in 81.8% vs 64.9%. In exercise studies, deterioration in health status was observed in 27.6% (367/1331), and 2.1% discontinued treatment due to worsening health (3% GET vs 1% AM). No advantage of GET over comparator groups was found in three different studies. The authors state that included studies differed substantially in design, diagnostic criteria, interventions, follow-up duration and outcome measures, and findings were synthesized qualitatively.

  64. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): diagnosis and management.2025 · review
    Summary

    This narrative review searched PubMed, Web of Science, Embase, and the Cochrane Library from inception to August 2025 and included 211 publications on ME/CFS diagnosis, pathophysiology, assessment, and treatment. It summarized pharmacological and non-pharmacological interventions. Reported examples include a double-blind, randomized, placebo-controlled trial of IVIG in 99 CFS patients that found an absence of dose-dependent efficacy; a Phase III rintatolimod study in 208 ME/CFS patients in which 51.2% of a severely debilitated subgroup (n = 21/41) had a ≥ 25% improvement in exercise treadmill test duration; a 12-week trial in 207 ME/CFS patients reporting significant reductions in fatigue with CoQ10 (200 mg) and nicotinamide adenine dinucleotide (20 mg); LDN showing significant improvement in 73.9% of 218 ME/CFS patients; and a pilot study of 55 ME/CFS patients in which oral minocycline produced favorable symptom improvements for 80% of treatment completers. A pooled analysis of 1,298 ME/CFS patients from eight trials associated CBT with significant reductions in fatigue severity and functional impairment. A pragmatic trial in 241 adolescents (aged 8–17) found no significant inter-group difference between GET and activity management for physical function on the Short-Form 36 at 6 months. A systematic review and meta-analysis reported a significant reduction in fatigue (Hedges’ g = -0.52) and an improvement in physical function with pacing compared with no treatment or routine care. Harms included GET-associated symptom exacerbation in a significant proportion of patients, and rintatolimod adverse events may occur. TCM findings should be cautiously interpreted because the available evidence is constrained by methodological limitations.

  65. CBT and graded exercise therapy studies have proven that ME/CFS and long COVID are physical diseases, yet no one is aware of that.2025 · review
    Summary

    This paper is a review/commentary, not a new study, and enrolled no patients. It argues that CBTplus and graded exercise therapy (GET) studies in ME/CFS and long COVID show the conditions are physical diseases. It discusses the PACE trial (n = 641), whose GET group had 160 participants, and reports that fitness did not improve; the same was seen in the CBTplus group. It also reports that CBTplus and GET did not lead to a reduction in CFS symptom count. It cites Dutch studies (8 months of CBTplus in adults, 5 months in adolescents, at least 16 weeks of guided self-instructions) that did not lead to an objective improvement of activity (actometer), and other studies showing no objective improvement in fitness according to VO2peak. In long COVID, the ReCOVer study found that 16 weeks of CBTplus did not lead to an objective improvement of activity (actometer). Adherence data include PACE dropout of 11% for CBTplus and 6% for GET, and the Stordeur evaluation (n = 655) with 41–62 h of CBTplus and GET over 6–8 months and a dropout rate of 2.8%. The paper states that the small, short-lived subjective improvement of fatigue after CBTplus and GET is not matched by an objective improvement of physical fitness or employment and illness benefit status. It does not report its own limitations.

  66. The potential therapeutic approaches targeting gut health in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a narrative review.2025 · review
    Summary

    This narrative review searched English peer-reviewed literature from January 1995 to January 2025 via PubMed, Scopus, and Web of Science to synthesize data on gut microbiota, inflammatory markers, and therapeutic outcomes in ME/CFS. The review did not report enrolling patients. It describes probiotic studies: an Italian pilot 8-week course improved well-being and reduced inflammation; in 15 ME/CFS patients, three strains improved neurocognitive function but no significant fatigue or physical activity reduction in only nine patients; Bifidobacterium infantis 35,624 in 48 patients lowered CRP, TNF-α, and IL-6. A 12-week Ubiquinol-10 randomized trial reported no significant fatigue improvement but reduced night-time awakenings; a 16-week randomized placebo-controlled trial of oral melatonin (1 mg) and zinc (10 mg) in 50 patients showed reductions in physical fatigue and improved quality of life. FMT: a retrospective study of 60 patients reported 70% response after four weeks and 58% maintained resolution for 15–20 years; another reported 17 of 21 patients with at least 60% improvement; a randomized placebo-controlled pilot in 11 patients (5 universal donor, 6 autologous) found no notable quality-of-life differences at 1 and 6 months. A Norway survey reported about 80% declined after graded exercise therapy; structured moderate activity over 12 to 26 weeks reduced fatigue compared with conventional/passive therapies; after a maximal exercise test, pain, fatigue, and confusion changed, with Clostridium in blood at 15 min and Bacilli increased at 48 h. Authors state current research lacks comprehensive insights and studies often produce conflicting findings, with varied diagnostic criteria and small samples.

  67. The PACE Trial's GET Manual for Therapists Exposes the Fixed Incremental Nature of Graded Exercise Therapy for ME/CFS.2025 · review
    Summary

    This review examined evidence used by White et al. about NICE guidance for ME/CFS; it did not enrol or treat participants. In the PACE trial, quality-of-life scores at 24 weeks and 52 weeks were 0.60 (GET) and 0.61 (CBT), and 0.59 (GET) and 0.63 (CBT), and CBT and GET did not have an effect on CFS symptom count. The review states 20% of PACE participants who improved subjectively deteriorated objectively (6MWT). In MAGENTA (n = 241; GET 123, AM 118), there was no evidence GET was better or more cost-saving than AM at 6 or 12 months; accelerometer activity fell at 3 and 6 months. GETSET showed no indication of an advantage or disadvantage of GET versus SMC for physical performance, and a significant difference at 15 months favouring SMC for fatigue. In Moss-Morris et al., subjective physical functioning improved 30% after GET while CPET deteriorated 15%. Reported harms included worsening in 58.3% (CBT) and 81.1% (GET) in an Oxford Brookes University study (n = 2274), and 14% (CBT) and 22.4% (GET) becoming bedridden; 82% of a 25% ME group survey (n = 437) were made worse by GET, and an Action for ME survey reported GET harmful in 60% of cases. A Dutch GET programme reported dropout of 55%, 73%, and 80% at 6, 9, and 12 months. The authors report no formal limitations section.

  68. Research progress on pathogenesis of chronic fatigue syndrome and treatment of traditional Chinese and Western medicine.2024 · review
    Summary

    This comprehensive review synthesized recent literature on Chronic Fatigue Syndrome (CFS) pathogenesis and traditional Chinese and Western medicine treatments; it did not enroll or analyze its own patient cohort, so setting was not reported. Cited studies described varied interventions. Shu et al. randomized 30 CFS patients to acupuncture or moxibustion at Zusanli and Guanyuan; after 4 and 10 weeks both alleviated fatigue symptoms by modulating the vagus nerve, with acupuncture showing superior short-term and moxibustion enhanced long-term clinical efficacy. Luo et al. studied 60 female CFS patients receiving 30-min or 60-min moxibustion three times per week for four weeks; 60-min moxibustion showed advantages for fatigue and depression. Qi Fengjun et al. allocated 60 CFS patients to massage or acupuncture for two treatment courses each lasting 10 days; massage showed significant therapeutic benefits. Liang Weili et al. divided 70 CFS patients; oral medication plus herbal-cake moxibustion was more efficacious than oral medication alone for fatigue and sleep quality. Borody et al. reported FMT therapeutic efficacy in 70% of cases (42 out of 60) with gastrointestinal symptoms. Adamson et al. observed improvement in 995 CFS patients after cognitive-behavioral and psychological interventions. Harms included lower incidence of nausea and diarrhea with moxibustion plus paroxetine than paroxetine alone; in a Norwegian survey approximately 80% of patients reported decline in health status after graded exercise therapy. The authors stated limitations including lack of rigorous trial design and safety data.

  69. Chronic inflammatory response syndrome: a review of the evidence of clinical efficacy of treatment.2024 · review
    Summary

    This literature review searched EBSCOhost Academic Search Premier, Proquest, Google Scholar, and the Cochrane Library in June 2022 for published treatments for chronic inflammatory response syndrome (CIRS), ME/CFS, and sick building syndrome. No patients were enrolled by the review; no comparison group, randomization, or follow-up duration was reported. The review reports 13 articles comprising 14 studies on CIRS treatment and also reviews CFS treatment studies. Named CIRS study sizes included 8, 13, 28, 14, 21, 156/111, 20, 35/4, 100, and 68/23. The review states the only treatment with documented clinical efficacy was the Shoemaker Protocol, described in 11 of the 13 articles; table entries list cholestyramine and vasoactive intestinal peptide as successful, while Rea’s antigen intradermal treatments had lack of objective data. CFS studies listed sizes including 49, 1518, 1030, 2036, 62, 409, 101, 171, 33, 32/18, 23, and 218; findings included some benefit for aripiprazole in 101 patients, high frequency of response for low-dose naltrexone in 218, and CBT/GET reported beneficial in six studies but noncurative. Reported side effects include constipation from cholestyramine, hyponatremia from desmopressin, and light-headedness from vasoactive intestinal peptides; medication intolerance was a barrier.

  70. Effects of graded exercise therapy and medical care on chronic fatigue syndrome2024 · review
    Summary

    This review article examined five studies published between 2013 and 2023, identified through PubMed, on treatments for CFS/ME in the working population. The interventions reviewed were GET, CBT, APT, SMC, and GES. The review reports that in White et al. (2013), with 641 participants over 52 weeks, recovery was CBT 22%, GET 22%, APT 8%, and SMC alone 7%; the chances of recovery were significantly higher for CBT and GET than for APT and SMC alone. In Sharpe et al. (2015), a follow-up of the 641 participants, 75% returned the long-term questionnaire and 44% received additional treatment; reduced fatigue and better physical and cognitive functioning were sustained for those originally assigned CBT or GET, while those initially assigned SMC or APT also improved. Clark et al. (2017) included 211 participants, with 107 assigned to GES and 104 to control; after 12 weeks, 34% of the GES group showed 8 points of improvement on SF-36 and 3 points on CFQ, compared with 14% improvement in the control group. Wilshire et al. (2018) reported that the GET group had better physical function ratings but not fatigue self-assessment, while the CBT group had better fatigue self-assessment but not physical function. Clark et al. (2021) reported that 78% returned questionnaires 15 months after commencement; GES improvements were sustained but without additional improvement and no significant difference compared to control. Side effects and withdrawals were not reported in the text. The authors state limitations concerning reliance on self-reported questionnaires and variability across studies.

  71. Graded exercise therapy and cognitive behavior therapy do not improve employment outcomes in ME/CFS.2023 · review
    Summary

    This paper is a review/commentary, not a new trial, and reports no own participants. It examines employment outcomes reported in studies of graded exercise therapy (GET) and cognitive behavior therapy (CBT) for ME/CFS, and discusses long Covid/PASC. In the PACE trial (641 participants), the percentage in the GET group reporting lost days of work increased from 83% at baseline to 86% at 12 months after randomization; in the CBT group the percentage was 84% both before and after treatment. In all study arms, the percentage receiving unemployment or disability benefits was higher after treatment. PACE reported that around 60% had improved and 22% had recovered after GET and CBT on subjective, self-reported measures; in the six-minute walking test the GET group showed a statistically significant but clinically insignificant improvement. Two other randomized trials, Prins et al. (278 participants) and O’Dowd et al. (153), reported no statistically significant differences in employment outcomes between intervention and control groups. Observational findings included Collin and Crawley (952 patients; subgroup of 394: 18% returned to work or increased work hours, 30% stopped or reduced work hours), a Belgian report (655 patients: employment status decreased; living from a sickness allowance rose from 54% to 57%), and Stevelink et al. (508 patients, 316 provided information: 9% returned to work, 6% stopped, net return-to-work of 3%). Vink and Vink-Niese found that standard interventions did not have an overall positive effect on work status.

  72. A scoping review of 'Pacing' for management of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): lessons learned for the long COVID pandemic.2023 · review
    Summary

    This scoping review searched six electronic databases up to 02/02/2022 and included 17 studies of pacing in people with ME/CFS. Designs were heterogeneous: RCTs, observational studies, a case series, and PACE trial sub-analyses. Pacing interventions included educational sessions, activity diaries, activity pacing self-management, and the energy envelope; comparators included relaxation therapy, pain physiology education, graded exercise therapy, cognitive behavioural therapy, and specialised medical care, while observational studies had no intervention. Outcomes covered symptoms, fatigue, physical function, pain, quality of life, self-efficacy, sleep, depression and anxiety. Findings were mixed. Antcliff et al. reported pacing improved mean scores of all symptoms; Kos et al. reported improved COPM performance (33% of group), satisfaction (42% of group), and CIS; Nijs et al. reported both improvements in CFS, COPM, and VAS and no improvement in SF-36, CFS, or CIS. White et al. reported pacing did not improve fatigue or physical function, but CBT and GET did. Geraghty et al. reported improved symptoms in 44% of respondents and worsened symptoms in 14%. Dougall et al. reported pacing worsened physical function in 25% of the group versus SMC 18%, GET 11%, and CBT 9%. White et al. reported recovery in 8% with pacing versus CBT 22%, GET 22%, and SMC 7%. Drop-outs were reported (Kos 25% experimental, 18% control; Meeus 5%; Nijs 22%; White 8%).

  73. The Draft Report by the Institute for Quality and Efficiency in Healthcare Does Not Provide Any Evidence That Graded Exercise Therapy and Cognitive Behavioral Therapy Are Safe and Effective Treatments for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2023 · review
    Summary

    This review examined the draft IQWiG report and the three trials it used on CBT and GET for ME/CFS: Janse et al. 2018, GETSET, and PACE. The PACE trial was a non-blinded study with n = 641. The review reports ME/CFS and notes long COVID/post-COVID syndrome. Setting and treatment duration were not reported. Treatments included iCBT/odCBT/pdCBT, GES, CBT and GET, compared with SMC or APT. Outcomes included adherence, CGI change, fatigue, physical functioning, six-minute walk test, step test, employment status, quality of life, symptom count and harms. Adherence was 16% (odCBT) and 19% (pdCBT); in GETSET, 43 (42%) adhered completely or very well, 31 (30%) moderately well, and 30 (29%) slightly or not at all. CGI positive change was 14% (GES) and 6% (SMC). At 52 weeks, fatigue scores were 20.3 (CBT) and 20.6 (GET); physical functioning scores were 58.2 (CBT) and 57.7 (GET). CBT and GET did not lead to objective short-, medium- or long-term improvement on the six-minute walk test; the step test showed no objective improvement. CBT had no effect and GET a negative effect on employment status. Quality-of-life net improvement was 2.3% after GET over APT and 0.5% after CBT over APT. Symptom-count improvement showed no statistically significant difference (p = 0.0916; p = 0.23; p = 0.0986). Cited surveys reported 20 percent of respondents said CBT worsened health and at least 50% for GET; an Oxford Brookes survey (n = 2274) reported worsening in 81.1% (GET) and 58.3% (CBT).

  74. Treatment Harms To Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome2023 · review
    Summary

    This preprint is a review, not a new trial: “The following sections review the most recent studies of patient treatment harms following CBT and GET.” It reports no enrolled participants, no comparison group and no treatment given by the author. It summarizes patient surveys and trials concerning ME/CFS and PASC. Kindlon (2011) reviewed 10 patient surveys from four countries: 51per cent of respondents (range = 28%–82%, n = 4338, eight surveys) reported GET worsened their health, and 20 per cent (range = 7%– 38%, n = 1808, five surveys) reported similar results for CBT. Lapp (1997) followed 31 patients for 12 days after a maximal exercise test and found the average relapse lasted 8.82 days, with 22 per cent still in relapse at 12 days. White and Etherington (2021) reviewed ten trials and reported drop-outs in 74/679 (11%) participants after GET and 41/600 (7%) after control interventions (RR (CI): 1.51 (1.03, 2.22)). McPhee et al. (2019) received data from 38 clinics; no clinic reported any cases of treatment-related harm. White et al. (2011) reported two serious adverse reactions (SARs) possibly related to treatment; Wearden et al. (2010b) reported no SARs due to therapy. Kindlon (2015) reported more than 50% of pwME/CFS said CBT and GET fell short of significant improvements and often led to worsened health. The paper does not state limitations for this review.

  75. Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.2022 · review
    Summary

    This narrative review describes rehabilitative treatments for CFS/ME. It does not report a new study; it summarizes trials. The main trial discussed is PACE, a four-arm trial that recruited over 600 patients. PACE compared specialist medical care alone with specialist medical care plus CBT, GET, or adaptive pacing therapy. Outcomes included functioning, fatigue, and six safety outcomes. The review states that CBT and GET improved functioning and reduced fatigue more than specialist medical care alone or specialist medical care plus adaptive pacing therapy. It reports no evidence of harm from CBT or GET in PACE. A more recent trial of guided self-help based on GET found no significant differences in safety outcomes compared with specialist medical care. The review also notes patient group surveys reporting that rehabilitation and GET in particular made some patients worse outside trials, and that rigidly applied programmes not tailored to symptom severity and disability may lead to worsening symptoms. No patients, enrollment numbers, follow-up durations, or withdrawal counts are reported for the review itself.

  76. Is It Useful to Question the Recovery Behaviour of Patients with ME/CFS or Long COVID?2022 · review
    Summary

    This literature review searched PubMed, Medline, the Cochrane Database of Clinical Trials, Academia, and Google Scholar from January 1980 to December 2021 for studies of CBT and GET in adults with ME/CFS that reported work status before and after treatment. Nine studies were summarised, including the PACE trial (n = 641), Huibers et al. (n = 151), and Prins et al. (n = 278). In the PACE trial, lost employment after CBT remained 84% and increased from 83% to 86% after GET. In Belgian clinics, working decreased from 18.3% to 14.9% and incapacity benefits rose from 54% to 57%; in British clinics, working decreased from 30% to 18%. Huibers et al. found more patients back at work without treatment at 4 and 12 months. O’Dowd et al. and Prins et al. found no statistically significant difference in work status, and Prins et al. found no statistically significant difference in hours worked. Van Berkel et al. found GET had no effect on work status at 3 and 12 months. Dropout was 38% in Stevelink et al. and 33%, 59%, and 72% after 6, 9, and 12 months of GET in Van Berkel et al. The Oxford Brookes University study (n = 2274) reported worsening of symptoms in 58.3% with CBT and 81.1% with GET, and increases in patients bedridden and dependent on help from 12.6% to 26.6% with CBT and 12.9% to 35.3% with GET. The authors state that most clinical trials did not report on harms from the therapies.

  77. The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.2022 · review
    Summary

    This review examined the evidence that Flottorp et al. used to support CBT and GET for ME/CFS after NICE's updated guidance. The review enrolled no patients itself; it discussed trials in ME/CFS, including PACE (n = 641), Gordon et al. (n = 22), Chalder et al. (n = 63), Windthorst et al. (n = 28) and an Oxford Brookes University study (n = 2274). Reviewed treatments included CBT, GET, APT, SMC, graded aerobic exercise, resistance training, I-CBT and waiting-list or usual care. In PACE, the chronic fatigue syndrome symptom count showed no statistically significant difference between GET and SMC (p = 0.0916), GET and APT (p = 0.23) or CBT and APT (p = 0.0986); EQ-5D net improvement was 2.3% after GET over APT and 0.5% after CBT over APT. Gordon et al. found no intervention significantly better than the other for any outcome. In Gotaas et al., the physical functioning difference between I-CBT and control was 6.8 points, below the authors' 10-point minimal important difference, and dropout was 20.5% vs. 6%. Oxford Brookes reported worsening in 58.3% (CBT) and 81.1% (GET); bedridden status increased from 12.6% to 26.6% (CBT) and 12.9% to 35.3% (GET). GETSET reported 14% (GES) and 6% (SMC) positive change, with only 8% subjectively benefiting from GES and up to 59% not tolerating treatment well. No limitations of the review were stated.

  78. Therapeutic approaches in chronic fatigue syndrome2021 · review
    Summary

    This E-Poster presentation reports a literature search, not a patient cohort, on therapeutic approaches in chronic fatigue syndrome (CFS). The authors searched main electronic databases with a paradigm combining CFS and psychopharmacological treatment or psychotherapy and included papers published between January 2000 and August 2020. No enrolled, started, or analysed patient numbers, follow-up duration, or trial registration were reported. The review states that anti-inflammatory drugs, antidepressants, mood stabilizers, anxiolytics, immunomodulatory drugs, and antivirals have been investigated, but the trials had low-quality designs, used various definitions of CFS, and different criteria for monitoring efficacy. For CBT, the authors conclude it may be promising for decreasing fatigue severity but larger trials are needed. For GET, they conclude it may be of some use for improving patients' ability to engage in activities, with caution because of the risk of over-exercising that may exacerbate core CFS symptoms. No drug may be considered first-line treatment. The authors state larger trials are needed to validate pharmacological and psychotherapeutic recommendations.

  79. Patients' experiences and effects of non-pharmacological treatment for myalgic encephalomyelitis/chronic fatigue syndrome - a scoping mixed methods review.2020 · review
    Summary

    This scoping mixed methods review asked what non-pharmacological treatments for ME/CFS do and what patients find important. It identified 16 papers from European studies, searching January 2009 to January 2019 and updating to 18 March 2020. Effect studies examined CBT, activity pacing and multidisciplinary rehabilitation including CBT and GET; qualitative studies examined CBT, GET self-help, self-management education, multimodal specialist care and the Lightening Process. CBT findings included reduced fatigue: Janse et al. reported 43% in iCBT groups reached normal fatigue vs 15% in waiting-list controls; Nijhof et al. reported school attendance 84% vs 51%, and 75% vs 16% reached full attendance at 6 months; Tummers et al. reported 33% vs 9% with clinically reduced fatigue in one study. Activity pacing and rehabilitation effects were inconsistent; Nunez et al. found worse SF-36 pain scores after 1 year in the rehabilitation group. Pinxsterhuis et al. found no group difference in physical functioning after 6 or 12 months. Janse et al. reported no serious adverse events; Cheshire et al. reported some felt worse with GET. The authors state CBT relieved fatigue but long-term effects need more investigation, and activity-pacing and rehabilitation studies are scarce with inconsistent effects.

  80. Management of chronic fatigue syndrome/myalgic encephalomyelitis in a pediatric population: A scoping review.2020 · review
    Summary

    This scoping review examined peer-reviewed research on managing chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) in a pediatric population aged under 18 years. The authors searched electronic databases and included 29 peer-reviewed research articles; no new participants were enrolled. The review grouped findings under nutrition/dietary components, exercise therapy, psychosocial factors, and multifaceted treatment. Included studies evaluated CBT with biofeedback, the Lightning Process plus standard medical care, aerobic graded exercise versus progressive resistance training, graded activity/exercise with family sessions, dietary changes, pacing versus STAIRway to Health, and other programs. Outcomes included fatigue severity, school attendance, physical function, anxiety and depression, quality of life, and global health. The review reports that included studies found lower fatigue severity and higher school attendance with CBT plus biofeedback, improvement with Lightning Process plus standard medical care, and no significant difference between aerobic graded exercise and progressive resistance training for physical capacity and QOL, while fatigue and depressive symptoms improved only in the aerobic group. No harms, side effects, worsening or withdrawals were reported in the recorded data. The authors state a lack of research in younger children and insufficient evidence for dietary modifications or supplements in prepubescent children.

  81. Graded exercise therapy does not restore the ability to work in ME/CFS - Rethinking of a Cochrane review.2020 · review
    Summary

    This review examined the amended Cochrane exercise review and the eight randomised controlled trials it included, with data from 1518 participants with ME/CFS from all diagnostic criteria. The treatments compared were exercise therapy versus no-treatment, relaxation and flexibility, or adaptive pacing. Outcomes included fatigue, physical functioning, objective exercise measures, quality of life, symptom count, and work. The review reports that exercise therapy probably reduces fatigue by 3.4 points on the Chalder fatigue scale (0 to 33) compared with no-treatment or relaxation and flexibility after 12 to 26 weeks; the effect after 52 to 70 weeks is uncertain. Physical functioning may moderately improve after 12 to 24 weeks (low evidence), and the effect after 52 to 70 weeks is uncertain; compared with adaptive pacing, exercise therapy may slightly improve physical functioning after 24 and 52 weeks. The authors report that objective outcomes in most included studies showed no objective improvement. In PACE (n = 640), 6MWT was 35.3 for no-treatment, GET had no effect on fitness, and symptom count did not differ significantly between GET and SMC (p = 0.0916) or GET and APT (p = 0.23). In an Oxford Brookes survey (n = 2,274), worsening after treatment was reported by 81.1% for GET, 85.9% for GET combined with CBT, and 58.3% for CBT combined with GET. In Wearden et al. (1998), 34.3% (23/67) complied fully with graded exercise versus 78.3% (54 of the 69 patients) with exercise placebo.

  82. Treating medically unexplained symptoms via improving access to psychological therapy (IAPT): major limitations identified.2020 · review
    Summary

    This review examined Improving Access to Psychological Therapies (IAPT) treatment protocols and early treatment data for medically unexplained symptoms, specifically ME/CFS; it enrolled no patients itself. It reports Kellett et al. IAPT service data: 172 MUS patients were treated out of 10,469 referred. Moving to recovery for depression was 32.33% for LTC and 29.35% for MUS; for anxiety it was 30.43% for LTC and 29.03% for MUS. Reliable improvement for depression was 39.07% for LTC and 33.70% for MUS; for anxiety it was 47.14% for LTC and 45.16% for MUS. Overall reliable recovery for MUS was 17.39%, and deterioration was 4.32%. Seventy-eight patients dropped out during treatment stages and 61 dropped out before treatment or did not complete treatment; 45.25% of MUS patients treated by IAPT did not complete treatment or dropped out after entering, and 4.6% completed intensive CBT. In Collin et al., 435 patients were followed for 1 year post-CBT; approximately 1/3rd reported some benefits, 5.7% counted themselves as no longer having ME/CFS, and 90%+ continued to report ME/CFS. Geraghty et al. found the majority of patients did not report CBT to be helpful, most found GET unhelpful or detrimental, and the biggest percentage reported self-pacing or guided pacing as most beneficial. Deary et al. found null to moderate size effects for reducing somatic symptoms. Edwards et al. reported most interventions out-perform usual care, even self-help guides. The authors state many patients with MUS, particularly ME/CFS, are unlikely to benefit from attending IAPT.

  83. Child and adolescent chronic fatigue syndrome/myalgic encephalomyelitis: where are we now?2019 · review
    Summary

    This review examined recent evidence on CFS/ME in children and young people, including impact, treatment and prognosis. It reported no enrolment, follow-up or treatment-duration figures for its own study and did not set out a search date or number of included studies. The review described PACE, an adult randomized controlled trial, as comparing SMC alone with SMC plus APT, CBT or GET; PACE demonstrated that CBT and GET added to SMC performed better as outpatient treatments than APT added to SMC or SMC alone. GETSET, an adult self-help graded exercise trial, reported that guided self-help added to SMC had a moderate effect on fatigue but less effect on physical functioning for those waiting for clinic therapy. In children and young people, five systematic randomized controlled trials demonstrated benefit from CBT treatment, while there was little evidence for GET. Burgess et al. reported improved physical functioning and social adjustment after a home-based, family-focused rehabilitative approach for severely affected housebound adolescents, but no substantial improvements in fatigue in all participants. Crawley et al. reported the Lightning Process plus SMC compared with SMC in mildly and moderately affected adolescents. A large online CBT trial was described as in progress. GETSET identified no serious adverse reactions in self-help GET in adults with CFS/ME. No withdrawal data were reported. The authors stated that current evidence is hampered by different diagnostic criteria, the heterogeneous nature of the condition, and limited number of small studies; they also stated that the evidence base in CYP is more limited.

  84. Myalgic encephalomyelitis/chronic fatigue syndrome: From pathophysiological insights to novel therapeutic opportunities.2019 · review
    Summary

    This review asks why pathophysiological insights in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) might point to treatments, and it examines treatment data for antioxidant and anti-inflammatory options. It reports no primary enrolment or analysis; it discusses patients diagnosed with ME/CFS by international consensus or Fukuda criteria and reviews CBT, GET, curcumin, NAC, CoQ10, melatonin, probiotics/prebiotics and molecular hydrogen. For the PACE trial, it reports that a year of CBT produced modest and short-term reductions in fatigue of some 10% compared with an untreated control group and a non-significant worsening of distance walked in six minutes. It also reports that CBT and GET reduced self-reported fatigue by some 13% compared with no treatment after 52 weeks, that GET improved six-minute walking distance by 31m compared with no treatment, and that GET for 12 months was associated with a 67m improvement versus 22m with specialist medical care alone. In 60 patients selected by international consensus criteria, graded exercise over a 12-month period was reported to worsen physical function and pain. Hydrogen-rich water studies in Parkinson’s disease (1,000 mL/day over a 48-week period) and rheumatoid arthritis (500 mL of 1 ppm for four weeks) reported improvements versus controls. The authors state these data are promising yet preliminary.

  85. Work Rehabilitation and Medical Retirement for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients. A Review and Appraisal of Diagnostic Strategies.2019 · review
    Summary

    This review asked whether work rehabilitation and medical retirement strategies, including CBT and GET, restore work ability in adults with ME/CFS. It searched PubMed, Medline, the Cochrane Database of Clinical Trials and Web of Science for literature published before April 2019 and reviewed 38 CBT and/or GET studies that reported on work status. Treatments included CBT, GET, graded activity, pacing, and antidepressants. Outcomes were employment, work hours, benefits, and fatigue. In Akagi 2001 et al. (n = 94), those who worked increased from 15 to 27, but the dropout rate was 46% (43/94). In Fulcher and White (n = 66), 39% were working or studying at least part time at trial entry, compared with 47% after treatment. McDermott et al. reported 9.2% (9/98) returned to work full time and 6.1% (6/98) part-time. In the PACE trial (n = 641), lost employment remained the same (84%) after CBT and increased from 83% to 86% after GET; income benefits increased from 10% to 13% (CBT) and from 14 to 20% (GET). Wittkowski et al. had two of six patients drop out; Marlin et al. (1998) reported 69% (49/71) lost to follow up. The authors state limitations include different selection criteria and variable follow-up periods.

  86. Graded exercise therapy for myalgic encephalomyelitis/chronic fatigue syndrome is not effective and unsafe. Re-analysis of a Cochrane review.2018 · review
    Summary

    This paper is a re-analysis of a Cochrane review of graded exercise therapy (GET) for chronic fatigue syndrome (CFS/ME). The review included eight randomised controlled studies and reported data from 1510 participants; the re-analysis examined those trials and objective outcomes. GET was compared with control groups or other interventions. In Fulcher, exercise capacity in the GET group improved by 4.3 per cent more than in its control group by 26 weeks, and patients reported improvement on a self-rated clinical global impression score of 1 or 2. In PACE, the net improvement in EQ-5D quality of life after GET over adaptive pacing at 52 weeks was 1 per cent; there was no statistically significant difference in CFS symptom count between GET and SMC (p = 0.0916) or APT (p = 0.23) at 52 weeks. The 6-minute walk benchmark was matched by 6.3 per cent in the GET group and 5 per cent in the SMC group, implying an effect of GET of 1.3 per cent (2/160). In FINE, there were no differences between pragmatic rehabilitation and GP treatment as usual on step test measures at 20 or 70 weeks. Wallman reported a 15 per cent drop in VO2max after GET. Harms included worsening of symptoms in 40 per cent of participants in one report; 37.3 per cent dropped out of the two graded exercise groups combined versus 21.7 per cent from the two control groups combined. The authors state most studies failed to report adverse reactions.

  87. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome.2017 · review
    Summary

    This comprehensive review examines benefits and harms of treatments for CFS/ME and makes recommendations. It reports no single enrolled or analysed total. Among the included studies, a phase II rintatolimod trial had 92 patients and a phase III trial had 234 patients; a rituximab RCT had 30 patients, with sustained overall improvement in 67% of CFS/ME patients versus 13% of controls. The PACE trial had 640 patients; a recovery paper reported 22% recovered in the CBT and GET groups, compared with 8% in the APT group and 7% in the SMC-only group. A survey of 828 Norwegian CFS subjects reported pacing useful in 96%, and 79% of patients with experience of graded training considered it worsened their health. CoQ10 plus NADH was studied in 80 patients, with maximum heart rate p=0.022. The review also describes harms: three patients administered acyclovir withdrew due to reversible renal failure, and two out of 13 participants developed neutropenia. The authors state no firm conclusions can be drawn because the few RCTs were small-scale, with a high risk of bias, and used different case definitions; nutritional studies were very limited, mostly small and without long-term follow-up.

  88. PACE investigators' response is misleading regarding patient survey results.2017 · review
    Summary

    This Open Peer Commentary Article reviews patient survey data published between 2001 and 2015 on ME/CFS. Five major patient surveys by Action for ME and The ME Association are pooled. Surveys asked patients about availability, helpfulness, improvement, worsening, or disability benefits for therapies including GET, CBT and pacing. In Action for ME 2011a (977 respondents), 48 per cent responded ‘yes’ for GET and 66 per cent for CBT being available on the NHS, compared with 90–94 per cent for pacing, medications and fatigue/condition management. In The ME Association 2010 survey (3099 respondents), 82 per cent wanted pacing, 28 per cent CBT and 24 per cent GET. In The ME Association 2010 survey (n = 4217), 22 per cent reported improvement with GET, 26 per cent with CBT and 71 per cent with pacing; 57 per cent reported worse symptoms from GET, 20 per cent from CBT and 5 per cent from pacing. The ME Association 2015 reported a net increase in patients on disability benefits after GET courses (+13%) and CBT courses (+10%), compared with a net decrease after pacing courses (−1%). The author states survey limitations should be borne in mind.

  89. Assessment of Individual PACE Trial Data: in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, Cognitive Behavioral and Graded Exercise Therapy are Ineffective, Do Not Lead to Actual Recovery and Negative Outcomes may be Higher than Reported2017 · review
    Summary

    The available text is an abstract of a paper described as an assessment of individual PACE trial data. It concerns Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). The abstract does not report how many people were enrolled or analysed, where they were from, the study design, the duration of treatment, or the comparison condition. It names Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET). The abstract records the PACE trial’s conclusion for CBT and GET and states that the trial yielded a 22% recovery rate. The abstract does not report a separate finding of the present assessment; it records the PACE trial’s stated conclusion and the 22% recovery figure. It does not report worsening, stopping treatment, side effects, between-group results, or before-and-after treatment results. The authors’ conclusion is not reported in the available abstract. Limitations stated by the authors are not reported in the available abstract; the available text is abstract only and lacks design, sample size and follow-up details.

  90. Can patients with chronic fatigue syndrome really recover after graded exercise or cognitive behavioural therapy? A critical commentary and preliminary re-analysis of the PACE trial2016 · review
    Summary

    This critical commentary and preliminary re-analysis asked whether PACE trial claims of recovery after graded exercise therapy (GET) or a special form of cognitive behavioural therapy (CBT) were justified. The PACE trial was an open-label randomised trial with more than 600 adult participants diagnosed with chronic fatigue syndrome (CFS) by the Oxford case definition. One group received no further treatment (Control); other groups received CBT, GET, or adaptive pacing therapy. Primary outcomes, obtained 52 weeks after treatment allocation, were self-rated fatigue and physical function. The commentary reports that PACE publications said 22% of CBT patients and 22% of GET patients recovered, versus 8% with adaptive pacing and 7% with Control. Self-rated fatigue and physical function improved in all groups, but significantly more so for CBT and GET. Using a definition almost identical to the original protocol, the authors calculated recovery in 7% of the CBT group, 4% of the GET group, and 3% of the Control group; rates for CBT and GET were not significantly higher than Control (Fisher’s exact p-values 0.199 and 0.770). They also report that revised criteria raised proportions meeting SF-36 physical function from 14% to 45%, Chalder Fatigue from 15% to 29%, and CGI from 12% to 34%; no recovered patient reached 589 m on the six-minute walking test. No side-effect or withdrawal counts are reported.

  91. The PACE Trial Invalidates the Use of Cognitive Behavioral and Graded Exercise Therapy in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: A Review2016 · review
    Summary

    The review examines the PACE trial and its follow-up articles from doctor and patient perspectives to assess CBT and GET in ME/CFS. The PACE trial was a multicenter trial in England involving 641 patients with ME/CFS. It compared cognitive behavioral therapy (CBT), graded exercise therapy (GET), adaptive pacing therapy, and specialist medical care. At 52 weeks, the review reports no difference in long-term outcomes between these treatments and a null effect. On the 6-minute walk test, the GET group walked 379 m within 6 min, an adjusted difference of 35 m beyond specialist medical care; the CBT group walked 354 m, 4 m beyond adaptive pacing therapy but 1.5 m less than specialist medical care. The review states these improvements did not reach statistical significance, for which an increase of at least 86 m was required. It reports that 22% of participants were considered recovered in both CBT and GET groups. Receipt of income benefits increased from 10% to 13% with CBT and from 14% to 20% with GET; illness/disability benefits increased from 32% to 38% and from 31% to 36%; income protection or private pensions increased by 100% in both groups. Harms reported in PACE included an increase in ME/CFS symptoms in 46%, musculoskeletal adverse events in 31%, neurological adverse events in 19%, and non-serious adverse events in 93%; 49% reported 4 and 51% more than 4 such events. Serious adverse events were 2% in CBT and 1% in the other 3 groups. 33 (5%) of 640 participants were lost to follow-up. The PACE authors stated recovery beyond 52 weeks was uncertain.

  92. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.2015 · review
    Summary

    This review was written from the viewpoint of the treating clinician to educate health care professionals and the public about Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). It reports no enrolled or analysed participant numbers. The authors describe supportive, symptomatic care and discuss pacing, graded exercise therapy (GET), medications for fatigue including stimulants and modafinil, fludrocortisone 0.1–0.2 mg/day or midodrine 10 mg up to four times daily, increased salt and electrolyte intake with fluids, isoprinosine (Imunovir), CoQ10 100–400 mg daily, eicosapentaenoic acid from omega-3 fish oil, tai chi and supportive yoga, meditation, long-term antibiotics/anti-parasitic/antiviral therapy, and psychotropic medications. They report that a study by Jason LA, Benton M (2009) found that those who stay within their energy envelope have significant improvements in physical functioning and fatigue severity compared to those who exceed their envelope. They also cite two randomized trials showing Rintatolimod (Ampligen®) benefits patients in the first three years of the illness who are more disabled. The review states GET is contraindicated and can be harmful for patients with ME/CFS using the CCC criteria, and that patients who go beyond their body’s available energy envelope will develop PEM. It states medications for fatigue are not generally recommended due to limited effectiveness and that stimulants have not been effective for cognitive dysfunction. It states fludrocortisone or midodrine help some patients, and that salt and fluids often help increase blood volume for fewer OI symptoms. The authors state there is no specific treatment for ME/CFS to date.

  93. Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.2013 · review
    Summary

    This review provides the theoretical and conceptual background for the Energy Envelope Theory and reviews evidence of its treatment efficacy in ME/CFS. It summarizes rehabilitation studies using energy conservation, pacing, and buddy/mentor support rather than a single trial. In one study, twelve patients with ME/CFS were recruited; half received a buddy and mentor for four months and half were controls who received no intervention; recipients had significant decreases in fatigue severity while controls had significant increases. A randomized study of forty-seven participants found significant increases in self-esteem, well-being, mastery, work, energy, and interpersonal relationships. A thirty-participant randomized buddy study reported greater reductions in fatigue severity and increases in vitality. In a trial of one hundred and fourteen patients randomly assigned to four interventions, those able to stay within energy envelopes had significant improvements in physical functioning and fatigue severity. Pacing programs were also summarized: Goudsmit et al. found differences for fatigue, somatic symptoms, and self-efficacy maintained at 12-month follow-up; Wallman et al. reported 91% rated themselves better and none felt worse; White et al. reported APT had little effect. Surveys cited found 26% of 2,338 respondents felt worse after CBT, 33.1% much worse and 23.4% slightly worse after graded exercise, and 34% worse after graded exercise. The authors note limitations to patient surveys because fidelity of interventions is not always clear.

  94. Treating chronic fatigue syndrome - a study into the scientific evidence for pharmacological treatments.2011 · review
    Summary

    The paper reports a questionnaire survey of 94 CFS patients from Queensland and New South Wales, recruited through support groups and newspaper and email advertisements, plus a search for randomised controlled trials. Patients filled out a questionnaire on current medicines and supplements; no treatment was given by the authors, and the survey had no comparison group. The 94 patients used 474 different medicines and supplements. Commonly used were antidepressants (41%), sedatives (27%), B vitamins (47%), magnesium (24%) and co-enzyme Q10 (7%). The search identified 20 RCTs. Findings included no difference for fluoxetine on fatigue or SF-36, no difference between treatment and placebo on individual questionnaires, and no effect for several agents including phenelzine, moclobemide, valaciclovir, terfenadine, melatonin, ginseng, bovine liver extract and a polynutrient supplement. One hydrocortisone trial reported 87% rated themselves improved versus 17% on placebo (p<0.001); another reported 53% vs. 29% (p=0.04) improvement in wellness score. Harm notes included diarrhoea with high-dose oral magnesium, long-term adrenal gland suppression with adrenal hormones, addiction and loss of effectiveness with benzodiazepines and opiates, and hormonal/lipid changes with DHEA. No worsening or stopping was reported. The authors state limitations.

  95. Pharmacological treatment of chronic fatigue syndrome: focusing on the role of antidepressants.2009 · review
    Summary

    This review did not run its own trial; it summarized published data on pharmacological treatment of chronic fatigue syndrome (CFS), identified through a PubMed literature search. The review covers antidepressants and other psychotropic agents in CFS. In included randomized, placebo-controlled trials, moclobemide vs. placebo (47 vs. 43) showed clinically global improvement 51 vs. 33% (OR = 2.16); KPI mean difference between two groups was 0.28 favoring MCB, and Vigor subscale on POMS mean difference was 0.51 favoring MCB. Overall response by subjective global impression was 51% with moclobemide vs. 23% with placebo. At 12 weeks, MIR failed to separate from PBO on FS; at 24 weeks, CBT + MIR showed significantly more reduction in FS scores than PBO + CBT, with an observed difference of 5.5 (95% CI = 15.4 – 22), whereas MIR + CBT failed to separate from PBO + CBT. Fluoxetine failed to separate from PBO on SFS and BDI scores, and failed to demonstrate benefit on listed outcome measures. The review lists harms: TCAs potentially induce sedation and orthostatic hypotension; MAOIs have hypertensive crisis; stimulant medications carry risks of misuse, abuse, withdrawal, and diversion. Authors state research does not support definitive conclusions about antidepressant efficacy in CFS.

  96. Chronic fatigue syndrome: an approach combining self-management with graded exercise to avoid exacerbations.2008 · review
    Summary

    This special report discusses why graded exercise therapy and pacing self-management are proposed for people with chronic fatigue syndrome (CFS). It is not a new trial; it reviews evidence and gives an approach. The text reports on an uncontrolled study of 20 cases of CFS given twelve weeks of paced and carefully monitored graded exercise therapy. That study found decreased psychological stress (reduced phobic anxiety, somatization and paranoid ideation) with no evidence of any exacerbation in symptoms. The report also cites a randomized controlled clinical trial in patients with CFS; it states that paced and individually-tailored graded exercise was superior to relaxation and flexibility training, but gives no numbers or outcome measure for that trial. It notes there were no drop-outs from the exercise group in that study once the programme commenced. The authors conclude there is currently strong evidence to support graded exercise therapy for people with CFS, state that graded exercise programmes can be undertaken without detrimental effects to the immune system, and say there is currently no evidence that graded exercise therapy, on average, causes harm. They also state that further work is required.

  97. Benefits of physical training in fibromyalgia and related syndromes.2007 · review
    Summary

    This literature review asked whether physical training benefits fibromyalgia (FM) and related syndromes, including chronic fatigue syndrome (CFS). The authors searched Medline (Ovid and PubMed) for articles on FM, CFS, therapy, rehabilitation, aerobic exercise, exercise, and cognitive behavioral therapy; no review-level number of patients or included studies was reported. The review summarizes trials of graded exercise/physical training and other treatments. A CFS study allocated 66 patients to a daily aerobic exercise program or to relaxation plus flexibility exercises; well-being improved in 55% versus 27%, and the authors reported benefits for fatigue and physical function. In FM studies, aerobic exercise was compared with flexibility sessions, with improvements in physical function and pain threshold but no difference in pain intensity or sleep disturbances. Other summarized programs reported improvements in pain, endurance, tender point count, fitness, function, mood, and fatigue, while some outcomes did not improve. A pregabalin trial (450 mg/day versus placebo) reported pain, fatigue, and sleep improvements. The review also reports adverse effects from antidepressant medications and a tolerable short-term increase in pain and fatigue during early exercise sessions.

  98. Antidepressants and cognitive-behavioral therapy for symptom syndromes.2006 · review
    Summary

    This review article examined antidepressant medications and cognitive-behavioral therapy for 11 somatic syndromes, including chronic fatigue syndrome. It did not report its own enrolments, analysed patients, setting, or follow-up; patient counts were not reported. The review described trials of antidepressants versus placebo and trials of CBT. Outcomes included global symptoms, pain, sleep, fatigue, mood, and energy. For CFS, the review reports that a systematic review found two interventions beneficial for improving but not curing symptoms: CBT and graded exercise. It reports that six of the seven RCTs of CBT on CFS found benefit, with an effect lasting for 5 years. Among antidepressant trials, two fluoxetine trials showed no benefit other than for depressive symptoms; one phenelzine trial showed improvement in multiple CFS symptoms, illness severity, and mood; and a moclobemide trial showed improvement in subjective vigor and energy. The review reports mixed evidence that antidepressants lead to overall improvement and states there is no randomized trial evidence demonstrating any efficacy for methylphenidate. The authors state that evidence for antidepressants in CFS is limited and insufficient for convincing conclusions.

  99. Practitioner review: chronic fatigue syndrome in childhood.2005 · review
    Summary

    This practitioner review discusses chronic fatigue syndrome in childhood and adolescence, drawing also on adult literature. It is not a new trial and reports no enrollment or analysis numbers. The authors describe assessment and management and focus on a rehabilitation program based on family cognitive behaviour therapy and graded activity, while also outlining pacing and supportive medical approaches. They state there are no randomized controlled trials demonstrating the effectiveness of this approach in children. They cite adult studies of cognitive behaviour therapy and/or graded exercise as improving disability and symptoms, and they cite open and clinical reports in children. For severely affected children, they cite inpatient rehabilitation based on the same principles as beneficial. For pacing, they state there is no empirical evidence for efficacy. They cite a supportive medical approach with low recovery rates: one-third over five years. They cite a randomized controlled trial of gammaglobulin infusions with a significant advantage over placebo but comparatively small gains, not routine practice. They state insufficient adult evidence for anti-depressants for CFS, with possible use for associated depression, insomnia and myalgia. The authors conclude that family cognitive behaviour therapy can be implemented and seems to hold most promise. They note no randomized controlled trials in children and little knowledge on pre-adolescents.

  100. Chronic fatigue syndrome: matching exercise to symptom fluctuations.2004 · review
    Summary

    This paper is a review of exercise for chronic fatigue syndrome (CFS), not a primary study; it reports no own enrolled or analysed participant numbers. It discusses Whiting et al23, a systematic review that included 44 studies and 2,801 patients with CFS, in which cognitive behavioral therapy (CBT) and graded exercise therapy showed promising results. An exercise training study22 in CFS patients lasting 4 to 6 months reported that the ability to perform aerobic exercise increased 13%; patients had less fatigue, a lower HR, a lower RPE, increased functional capacity, and fewer symptoms. In a large-scale study25, 1,092 veterans with Gulf War veterans' illnesses (GWVI) were randomly assigned to one of four treatment arms; neither aerobic exercise nor CBT had a significant impact on physical function, but both treatments, especially exercise, resulted in less fatigue, fewer cognitive symptoms, less distress, and improved mental health functioning. Clapp et al8 found no changes immediately after 30 minutes of light, intermittent exercise (three 10-minute bouts) or 1 week later; all10 patients believed they could not walk for 30 minutes without exacerbating symptoms. Reported harms include that exercise can provoke anxiety and a feeling of increased vulnerability to pain and fatigue, fatigue may be greater for the first few days, and a rapid introduction of overly strenuous exercise is likely to exacerbate symptoms. The authors state that CFS is difficult to study because patients are heterogeneous and symptoms fluctuate.

  101. Chronic fatigue syndrome: traditional and community-based approaches to rehabilitation.2004 · review
    Summary

    This narrative review summarised and critically reviewed existing studies of psychological and psychosocial rehabilitation for chronic fatigue syndrome (CFS), searching Medline, PSYCHINFO, CINAHAL, ERIC and the Science Citation Index. Reviewed treatments included CBT with graded activity, graded exercise, activity pacing, supportive counselling, multidisciplinary inpatient and community-based programmes. Sharpe et al. 1996 reported 73% CBT achieved satisfactory outcome vs. 27% usual care, 73% vs. 23% improved function by >10 points, and 63% vs. 20% improved work status. Fulcher & White 1997 reported 51% in the exercise group improved vs. 27% of controls. Wearden et al. 1998 reported exercise improved fatigue and functional work capacity at 12 and 26 weeks; fluoxetine improved depression at 12 weeks, not sustained at 26 weeks. Powell et al. 2001 reported all three intervention groups improved more than controls at one-year follow-up. Ridsdale et al. 2001 found no differences between CBT and counselling at 3 and 6 months; 53% of the original sample were fatigue cases at 6 months. Marlin et al. 1998 reported 61% returned to gainful employment, 27% functioned at a level equivalent to employment, and 12% remained on disability. Dropout rates included 42% in exercise + fluoxetine, 38% CBT in Prins et al. 2001, and 36% cognitive therapy in Ridsdale et al. 2001. The authors state current evidence for complete and enduring benefit of any single approach remains relatively weak, and many studies are limited by absence of a placebo control group, high dropout rates and selection bias.

  102. Psychological treatment of patients with chronic toxic encephalopathy: lessons from studies of chronic fatigue and whiplash.2003 · review
    Summary

    This review asked whether psychological treatment or cognitive rehabilitation helps patients with chronic toxic encephalopathy (CTE), using comparable evidence from chronic fatigue syndrome (CFS) and chronic whiplash-associated disorder (WAD). PubMed and PsychLIT were searched from inception to June 2000. Of 34 selected studies, 24 evaluated CFS, 5 WAD, and 5 CTE. Treatments included CBT, CBT plus graded exercise or graded activity, cognitive rehabilitation, relaxation, group therapy and other programs; comparisons included support groups, natural course, relaxation, counseling, controls and untreated patients. Outcomes included fatigue severity, functional impairment, quality of life, physical functioning, symptoms, work status, neuropsychological measures and satisfaction. In CFS, one quality A trial reported CBT was more effective than guided support groups or natural course for fatigue severity and functional impairment; other trials reported no significant differences between CBT and relaxation, CBT and counseling, or three brief treatment conditions. CTE cognitive rehabilitation studies were quality C and gave inconsistent results. Recorded harms were high dropout in a CFS trial, 33% dropout in another, refusal of therapy, and an increase of symptoms at 6-months’ follow-up after a CTE program. The authors state few treatment studies and no randomized controlled trials for WAD or CTE.

  103. Behavioral medicine approaches to somatoform disorders.2002 · review
    Summary

    This review examined research evidence on cognitive–behavioral therapy (CBT) for somatoform disorders, including chronic fatigue syndrome; searches covered 1970 to February 2001. In chronic fatigue syndrome studies, Sharpe et al. (1996) randomized 60 patients to CBT with graded activity for 16 sessions or usual treatment, and Deale et al. (1997) randomized 60 to 13 sessions of CBT or relaxation training. Fulcher & White (1997) randomized 66 to graded aerobic exercise or flexibility exercises and relaxation; Lloyd et al. (1993) randomized 90 patients across CBT with graded activity and DLE, CBT with graded activity and placebo, clinic visits and DLE, and clinic visits and placebo; Friedberg & Krupp compared group CBT with no treatment. Outcomes included the Karnofsky scale, a depression measure, and satisfactory or good outcome. At 7 months, Sharpe et al. found satisfactory outcome in 73% with CBT versus 27% with usual treatment (odds ratio 7.56). At 6 months, Deale et al. found good outcome in 70% versus 19% with relaxation (odds ratio 8.64). Fulcher & White reported good outcome in 52% with aerobic exercise versus 27% with flexibility exercises (2.72 [1.02–7.24]). Lloyd et al. found no differences between groups on the Karnofsky scale or depression at 3 months; Friedberg & Krupp reported no effect for group CBT. Dropouts were 0 in Sharpe, 3 CBT and 4 relaxation in Deale, 4 aerobic and 3 flexibility in Fulcher & White, and 1 in Group 3 and 1 in Group 4 in Lloyd. Side effects were not reported.

  104. Chronic fatigue syndrome and fibromyalgia: clinical assessment and treatment.2001 · review
    Summary

    This review examined treatment literature for chronic fatigue syndrome (CFS) and fibromyalgia (FM); it did not report its own enrolled participants, setting, or follow-up. It described studies of Ampligen, antidepressants (fluoxetine, amitryptaline), NADH, massage, essential fatty acids, cognitive-behavioral treatment (CBT) and graded activity-oriented CBT (GA/CBT), graded exercise, pacing/envelope theory, and other alternative or interdisciplinary approaches. Duration was reported only for GA/CBT trials: 13 to 16 sessions. Many cited trials had controlled, randomized, or crossover designs, but the review gave no single pooled comparison. In cited studies, fluoxetine had no effect on CFS or depression symptoms in one controlled study and only a temporary effect on depression symptoms in another; a later essential-fatty-acid trial failed to replicate earlier findings; and NSAIDs were not significantly associated with improved outcomes in a meta-analysis of 49 FM treatment studies. About one-third of patients responded favorably to NADH with at least 10% improvement in symptom scores. CFS patient ratings ranked antiallergy/antiyeast diets and biofeedback/stress management at 24–30% favorable to highly favorable. The review notes Ampligen reports of poor outcomes and adverse reactions, states drug hypersensitivity and adverse reactions are not uncommon, and says GA/CBT may trigger symptom flareups in clients without fear-based avoidance. It states that clinical-study participants are usually from tertiary care centers, so representativeness is unclear, and that controversy over theory-driven CBT for CFS remains unresolved. It also states low-level exercise should be discontinued if it worsens symptoms.

  105. Cognitive behavior therapy for chronic fatigue syndrome: efficacy and implications.1998 · review
    Summary

    This review examined cognitive behavior therapy (CBT) for chronic fatigue syndrome (CFS). Butler et al. 1991 (case series, 32 patients) reported that a rehabilitative behavioral form with a mean of 8 sessions was followed by improvement from baseline in fatigue, disability, and depression; the table notes 18 patient refusals and 5 dropouts. Lloyd et al. 1993 (randomized controlled trial; 41 1 49 patients) compared a brief rehabilitative form (6 individual sessions) with medical care and found no difference in functional impairment at 3 months. Sharpe et al. 1996 (randomized controlled trial; 30 1 30; 60 patients recruited) compared 16 individual sessions with medical care: approximately three quarters of CBT patients had a good outcome at 12 months versus one quarter with medical care alone, fatigue, self-rated disability, depression, and timed walking distance improved more with CBT, and no patients dropped out. Deale et al. 1997 (30 1 30) compared 13 individual sessions with 13 relaxation sessions and found greater reduction in disability, fatigue, and depression at 6 months. A separate randomized trial found graded increases in activity substantially more effective than flexibility exercises for disability and symptoms; patients were not harmed or made worse, while another graded exercise trial in unselected patients had a high refusal and dropout rate. The authors state there is now good evidence from 2 independent randomized clinical trials to support CBT efficacy, that the treatment effect is substantial although few patients are cured, and that intensive individual CBT remains the treatment of choice.

  106. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.1998 · lab study · 136 in the study
    Summary

    This six-month randomised, placebo- and therapist-contact-controlled trial asked whether graded exercise and fluoxetine treat chronic fatigue syndrome. It enrolled 136 patients from consecutive referrals to a university department of medicine out-patient clinic across north-west England and north Wales between June 1993 and March 1995. Patients were allocated to exercise plus 20 mg fluoxetine (33), exercise plus placebo drug (34), exercise control plus 20 mg fluoxetine (35), or exercise control plus placebo drug (34). Graded exercise was 20 minutes at least three times per week; fluoxetine was a fixed daily 20 mg dose; all attended the hospital on eight occasions at weeks 0, 1, 2, 4, 8, 12, 20 and 26. Outcomes included fatigue scale, MOS scales, HAD scales and functional work capacity at weeks 12 and 26. Exercise resulted in fewer patients with case level fatigue than appointments only at 26 weeks (12 (18%) v. 4 (6%) P=0.025) and improved functional work capacity at week 12 (mean change 2.0, 95% CI 0.60-3.49; P=O.OOS) and week 26 (mean change 1.9, 95% CI 0.15-3.69; P=0.03). Fluoxetine had no effect on the fatigue scale at week 12 or week 26 and no significant effect on functional work capacity; it significantly reduced the HAD depression score at week 12 (P=0.04) but not at week 26 (P=0.28). Eleven subjects dropped out because of medication side-effects (two taking placebo drug); drop-out was greater with exercise than non-exercise (25/68 (37%) v. 15/69 (22%)), while fluoxetine (24/68 (36%)) versus placebo drug (16/69 (24%)) did not reach significance.

  107. A double-blind placebo controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome (CFS)1996 · lab study · 136 in the study
    Summary

    This six-month prospective randomised trial allocated 136 patients meeting Oxford research criteria for CFS, recruited from a University department of medicine outpatient clinic, to four treatment cells: exercise and fluoxetine; exercise and placebo drug; appointments and fluoxetine; appointments and placebo drug. Fluoxetine was given at 20 mg/day; graded exercise was delivered by a physiotherapist. The drug treatment was double-blind, and patients were blind to the exercise programme. The study tested efficacy and acceptability of these treatments for CFS patients with or without DSM-IIIR depressive disorders. Outcomes included fatigue, functional work capacity, health perception, completion, and full recovery from fatigue symptoms. Ninety (66%) patients completed the trial, and patients were more likely to drop out of exercise than non-exercise treatment (p = 0.05). There was a non-specific treatment effect on most measures. When patients complied fully with exercise, exercise had a significant effect on fatigue (p = 0.04), functional work capacity (p < 0.00 I) and health perception (p = 0.03). In patients who complied, fluoxetine had a significant effect on fatigue (p = 0.02). On intention to treat, 12 (18%) patients in the exercise groups had fully recovered from their fatigue symptoms at six months compared with four (6%) who did not receive exercise (p = 0.004). Significant improvement with exercise only occurred in patients with DSM-IIIR depressive disorders who were prescribed fluoxetine. Side-effect counts and stated limitations were not reported in the available text.

A little hope, every Sunday

New recovery stories and data-driven research on ME/CFS and long COVID. Ideas worth considering, and the evidence behind them.

Free · Unsubscribe anytime